| [100010] Filing information | [200100] Independent auditors report | [300100] Statement of financial position, order of liquidity | |||
| [300200] Statement of insurance/ takaful operations, nature of expense | [300300] Statement of shareholders operations, nature of expense | [300400] Statement of other comprehensive income, before tax, insurance operations | |||
| [300500] Statement of other comprehensive income, before tax, shareholders operations | [300600] Statement of cash flows, indirect method, insurance operations | [300700] Statement of cash flows, indirect method, shareholders operations | |||
| [300800] Statement of changes in equity | [400100] Notes forming part of accounts |

| [100010] Filing information |
|   | English [member] | |
|---|---|---|
| Start Date | 2021-01-01 | 2020-01-01 |
| End Date | 2021-12-31 | 2020-12-31 |
| Filing information [line items] | ||
| Disclosure of entity information [abstract] | ||
| Name of reporting entity | Allied Cooperative Insurance Group | |
| Company symbol code| ISIN code | 8150 | SA000A0SR838 | |
| Sector| Industry group | Financials | Insurance | |
| Disclosure of document information [abstract] | ||
| Whether entity wants to report opening statement of financial position | No | |
| Period covered by financial statements | Annual | |
| Reporting period start date | 2021-01-01 | 2020-01-01 |
| Reporting period end date | 2021-12-31 | 2020-12-31 |
| Description of nature of financial statements | Standalone | |
| Status of financial statements | Audited | |
| Description of presentation currency | Saudi Arabia, Riyals | |
| Level of rounding used in financial statements | Thousands | |
| [200100] Independent auditors report |
|   | Primary auditor [member] | Second primary auditor [member] |
|---|---|---|
|   | English [member] | English [member] |
| Start Date | 2021-01-01 | 2021-01-01 |
| End Date | 2021-12-31 | 2021-12-31 |
| Auditors information [line items] | ||
| Details of auditors signing report [abstract] | ||
| Name of auditor signing report | Maher Al-Khatieb | Abdullah M. AlAzem |
| Registration number of auditor | 514 | 335 |
| Details of audit firm [abstract] | ||
| Name of audit firm | Dr. Mohamed Al-Amri & Co.Certified Public Accountants | Al Azem, Al Sudairy, Al Shaikh & PartnersCertified Public Accountantsmember firm Crow nternational |
| Registration number of audit firm | 323/11/66 | 148/11/323 |
| Contact number of audit firm | 12 283 0112 | 112175000 |
| Address of audit firm | P. O. Box 784Jeddah 21421Kingdom of Saudi Arabia | P.O 10504 Riyadh 11443 |
|   | English [member] |
|---|---|
| Start Date | 2021-01-01 |
| End Date | 2021-12-31 |
| Auditors report [line items] | |
| Disclosures of auditors report [text block] | To the Shareholders of Allied Cooperative Insurance Group (ACIG))(A Saudi Joint Stock Company)Report on the Audit of Financial Statements |
| Contents of auditors report [abstract] | |
| Nature of auditors opinion | Unmodified opinion |
| Auditors opinion | OpinionWe have audited the financial statements of Allied Cooperative Insurance Group (ACIG), (A Saudi JointStock Company) (the “Company”), which comprise the statement of financial position as at 31 December2021, and the statements of income, other comprehensive income, changes in equity and cash flows for the year then ended and the summary of significant accounting policies and other explanatory information.In our opinion, the accompanying financial statements present fairly, in all material respects, the financial position of the Company as at 31 December 2021, and its financial performance and its cash flows for the year then ended in accordance with International Financial Reporting Standards (“IFRS”) as endorsed in the Kingdom of Saudi Arabia and other standards and pronouncements issued by Saudi Organization for Chartered and Professional Accountants (“SOCPA”). |
| Basis of opinion | Basis of OpinionWe conducted our audit in accordance with International Standards on Auditing (“ISAs”) as endorsed in the Kingdom of Saudi Arabia. Our responsibilities under those standards are further described in the “Auditors’ Responsibilities for the Audit of the Financial Statements” section of our report. We are independent of the Company in accordance with the professional code of conduct and ethics, as endorsed in the Kingdom of Saudi Arabia, that are relevant to our audit of the financial statements, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion. |
| Key audit matters | Key Audit MattersKey audit matters are those matters that, in our professional judgment, were of most significance in our audit of the financial statements of the current year. These matters were addressed in the context of our audit of the financial statements as a whole, and in forming our opinion thereon, and we do not provide a separate opinion on these matters. For the matter below, a description of how our audit addressed the matter is provided in that context: To the Shareholders of Allied Cooperative Insurance Group (ACIG)(A Saudi Joint Stock Company)Key Audit Matters (Continued)Key Audit Matter How our audit addressed the key audit matterValuation of ultimate claim liabilities arising frominsurance contractsAs at 31 December, 2021, gross outstanding claims and reserves including claims incurred but not reported (IBNR), premium deficiency reserves and other technical reserves amounted to SAR 153 million as reported in Note 8.1 to the financial statements.The valuation of the ultimate liabilities arising from claims made under insurance contracts is a key judgmental area for the management given the level of subjectivity inherent in estimating the impact of claim events that have occurred and incurred but not reported for which the ultimate outcome remains uncertain.The Company uses an external actuary (the “management expert”) to provide them with the estimates of these claims. A range of method were used by the management expert to determine these claims. This requires significant judgments relating to factors and assumptions such as inflation, claims development patterns and regulatory requirements. Due to significance of amount involved, the exercise of significant judgment by the management in the process for determination of ultimate claims liabilities, we have determined it to be a key audit matter.Refer to note 2(e)(i) regarding the use of judgments and estimates, notes 3(i) and 3(iv) of accounting policies, and note 8 for the related disclosure. Our audit procedures, among other procedures, include the following: Assessed the design and implementation and tested the operative effectiveness of key control over management processes for claims processing and payment, including controls over the completeness and accuracy of the claims estimate recorded. Evaluated the competence, capabilities and objectivity of the management’s expert based on their professional qualifications and experience and assessed their independence. Engaged our actuarial expert to assess the methodology and assumptions used by the management in determining the reserve for claims incurred but not reported (IBNR), premium deficiency reserves and other technical reserves. We also reviewed the actuarial reserve report issued by the Company’s appointed actuary. Performed substantive tests on the amounts recorded for a sample of claims notified and paid; including comparing the outstanding claims amount to appropriate source documentation to evaluate the valuation of outstanding claim reserves. Assessed the adequacy of the related disclosures. |
| Responsibilities of management and those charged with governance for financial statements | Other informationManagement is responsible for the other information in the Company’s annual report. Other information consists of the information included in the Company’s 2021 annual report, other than the financial statements and our auditors’ report thereon, which is expected to be made available to us after the date of this auditors’ report.Our opinion on the financial statements does not cover the other information and we do not and will not express any form of assurance conclusion thereon.In connection with our audit of the financial statements, our responsibility is to read the other information identified above and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit, or otherwise appears to be materially misstated.When we read the annual report, if we conclude that there is a material misstatement therein, we are required to communicate the matter to those charged with governance.Responsibilities of Management and Those Charged with Governance for the Financial StatementsManagement is responsible for the preparation and fair presentation of the financial statements in accordance with IFRS, as endorsed in the Kingdom of Saudi Arabia and other standards and pronouncements issued by SOCPA, the applicable requirements of the Regulations for Companies in the Kingdom of Saudi Arabia and the Company’s by-laws, and for such internal control as management determines is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.In preparing the financial statements, the Management is responsible for assessing the Company’s ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the Management either intend to liquidate the Company or to cease operations, or have no realistic alternative but to do so.Those charged with governance (i.e. Board of Directors) are responsible for overseeing the Company’sfinancial reporting process. |
| Auditors responsibilities for audit of financial statements | Auditors’ responsibilities for the audit of the financial statementsOur objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditors’ report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with International Standards on Auditing “ISAs” as endorsed in the Kingdom of Saudi Arabia will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements. To the Shareholders of Allied Cooperative Insurance Group (ACIG)(A Saudi Joint Stock Company)Auditors’ responsibilities for the audit of the financial statements (Continued)As part of an audit in accordance with ISAs as endorsed in the Kingdom of Saudi Arabia, we exercise professional judgment and maintain professional skepticism throughout the audit. We also: Identify and assess the risks of material misstatement of the financial statements, whether due to fraud or error, design and perform audit procedures responsive to those risks, and obtain audit evidence that is sufficient and appropriate to provide a basis for our opinion. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal control; Obtain an understanding of internal control relevant to the audit in order to design audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control; Evaluate the appropriateness of accounting policies used and the reasonableness of accounting estimates and related disclosures made by Management; Conclude on the appropriateness of the Managements’ use of the going concern basis of accounting and, based on the audit evidence obtained, whether a material uncertainty exists related to events or conditions that may cast significant doubt on the Company’s ability to continue as a going concern. If we conclude that a material uncertainty exists, we are required to draw attention in our auditors’ report to the related disclosures in the financial statements or, if such disclosures are inadequate, to modify our opinion. Our conclusions are based on the audit evidence obtained up to the date of our auditors’ report. However, future events or conditions may cause the Company to cease to continue as a going concern; and Evaluate the overall presentation, structure and content of the financial statements, including the disclosures, and whether the financial statements represent the underlying transactions and events in a manner that achieves fair presentation;We communicate with those charged with governance regarding, among other matters, the planned scope and timing of the audit and significant audit findings, including any significant deficiencies in internal control that we identify during our audit.We also provide those charged with governance with a statement that we have complied with relevant ethical requirements regarding independence, and to communicate with them all relationships and other matters that may reasonably be thought to bear on our independence, and where applicable, related safeguards. INDEPENDENT AUDITORS’ REPORT (CONTINUED)To the Shareholders of Allied Cooperative Insurance Group (ACIG)(A Saudi Joint Stock Company)Auditors’ responsibilities for the audit of the financial statements (Continued)From the matters communicated with those charged with governance, we determine those matters that were of most significance in the audit of the financial statements of the current year and are therefore the key audit matters. We describe these matters in our auditors’ report unless law or regulation precludes public disclosure about the matter or when, in extremely rare circumstances, we determine that a matter should not be communicated in our report because the adverse consequences of doing so would reasonably be expected to outweigh the public interest benefits of such communication. |
| Report on other legal and regulatory requirements | Report on Other Legal and Regulatory RequirementsAs at year end, the solvency margin reached to -119% (31 December 2020: 100%). In compliance with the Article68(c) of the Implementation Regulations for Insurance Companies, the Company has taken certain remedial measures on immediate basis that include increase the share capital, adjusting insurance premiums and reducing cost (Refer Note 2) |
| Date of signing audit report by auditor | 2022-04-05 |
| [300100] Statement of financial position, order of liquidity |
| Start Date | 2021-01-01 | 2020-01-01 | Note No. |
|---|---|---|---|
| End Date | 2021-12-31 | 2020-12-31 | |
| Statement of financial position [abstract] | |||
| Assets [abstract] | |||
| Insurance/ takaful operations assets [abstract] | |||
| Property and equipment, net, insurance/ takaful operations assets | 10,996 | 10,065 | |
| Due from related parties, insurance/ takaful operations assets | 1,985 | 1,985 | |
| Deferred policy acquisition costs | 44,053 | 31,659 | |
| Reinsurers/ retakaful share of unearned premiums/ contributions | 34,703 | 27,393 | |
| Prepayments and other assets, insurance/ takaful operations assets | 57,950 | 63,115 | |
| Due from shareholders operations | 31,249 | ||
| Premiums/ insurance receivables/takaful contributions receivable, net | 98,415 | 98,638 | |
| Reinsurers/ retakaful share of outstanding claims/ benefits, net | 12,955 | 11,908 | |
| Time (Murabaha) deposits, insurance/ takaful operations assets | 182,367 | 119,331 | |
| Cash and cash equivalents, insurance/ takaful operations assets | 52,973 | 69,686 | |
| Reinsurers/ retakaful share of mathematical reserves | 8,498 | 8,020 | |
| Other assets, insurance/ takaful operations assets | 3,229 | 5,222 | |
| Total insurance/ takaful operations assets | 539,373 | 447,022 | |
| Shareholders assets [abstract] | |||
| Statutory deposit | 30,000 | 30,000 | |
| Prepayments and other assets, shareholders assets | 4,884 | 4,084 | |
| Available-for-sale investments, shareholders assets | 50,721 | 49,259 | |
| Other receivables, net | 1,871 | 1,794 | |
| Cash and cash equivalents, shareholders assets | 0 | 75,251 | |
| Total shareholders assets | 87,476 | 160,388 | |
| Total assets | 626,849 | 607,410 | |
| Liabilities and equity [abstract] | |||
| Insurance/ takaful operations liabilities and surplus (deficit) [abstract] | |||
| Insurance/ takaful operations liabilities [abstract] | |||
| Gross unearned premiums/ contributions | 301,744 | 264,469 | |
| Unearned commission income | 1,261 | 1,426 | |
| Employees end of service benefits, insurance/ takaful operations liabilities | 11,431 | 12,942 | |
| Surplus distribution payable | 5,991 | 6,409 | |
| Technical reserve for insurance/takaful operations | 37,525 | 11,998 | |
| Reinsurers/ retakaful balance payable | 24,749 | 16,661 | |
| Gross outstanding claims/ benefits including IBNR payable | 115,470 | 94,737 | |
| Other technical reserves | 20,789 | 10,142 | |
| Accrued expenses payable, insurance/ takaful operations liabilities | 17,430 | 23,264 | |
| Other liabilities, insurance/ takaful operations | 2,983 | 4,974 | |
| Total insurance/ takaful operations liabilities | 539,373 | 447,022 | |
| Total insurance/ takaful operations liabilities and surplus (deficit) | 539,373 | 447,022 | |
| Shareholders liabilities and equity [abstract] | |||
| Shareholders liabilities [abstract] | |||
| Zakat payable | 19,258 | 11,000 | |
| Due to insurance/ takaful operations | 31,249 | ||
| Accrued expenses payable, shareholders liabilities | 1,871 | 1,794 | |
| Other liabilities, shareholders liabilities | 1,525 | 899 | |
| Total shareholders liabilities | 53,903 | 13,693 | |
| Shareholders equity [abstract] | |||
| Equity attributable to owners of parent [abstract] | |||
| Share capital | 141,000 | 141,000 | |
| Retained earnings (accumulated losses) | -116,015 | -1,431 | |
| Reserve of disposal group held for distribution/ sale | 8,588 | 7,126 | |
| Total equity attributable to equity holders of company | 33,573 | 146,695 | |
| Total shareholders liabilities and equity | 87,476 | 160,388 | |
| Total insurance/ takaful operations liabilities, surplus (deficit) and shareholders liabilities and equity | 626,849 | 607,410 |
| [300200] Statement of insurance/ takaful operations, nature of expense |
| Start Date | 2021-01-01 | 2020-01-01 | Note No. |
|---|---|---|---|
| End Date | 2021-12-31 | 2020-12-31 | |
| Statement of insurance/ takaful operations [abstract] | |||
| Statement of insurance/ takaful operations and accumulated surplus (deficit) [abstract] | |||
| Income from insurance/ takaful operations [abstract] | |||
| Net premiums/ contributions earned [abstract] | |||
| Net premiums/ contributions written [abstract] | |||
| Gross premiums/ contributions written | 592,588 | 515,117 | |
| Excess of loss expense | 4,339 | 4,524 | |
| Reinsurance/ retakaful premiums ceded | 74,192 | 61,133 | |
| Net premiums/ contributions written | 514,057 | 449,460 | |
| Changes in unearned premiums/ contributions | 29,965 | 4,039 | |
| Net premiums/ contributions earned | 484,092 | 445,421 | |
| Reinsurance/ retakaful commissions | 4,698 | 4,112 | |
| Investment income from insurance/ takaful operations, net | 1,539 | 2,138 | |
| Fees and other income from insurance/ takaful operations | 285 | 6,260 | |
| Other non-operating income from insurance/ takaful operations | 124 | 12 | |
| Total income from insurance/ takaful operations | 490,738 | 457,943 | |
| Cost and expenses [abstract] | |||
| Net claims/ benefits incurred [abstract] | |||
| Net claims/ benefits paid [abstract] | |||
| Gross claims/ benefits paid | 430,130 | 382,842 | |
| Reinsurance/ retakaful share of gross claims/ benefits paid | 37,488 | 38,123 | |
| Net claims/ benefits paid | 392,642 | 344,719 | |
| Changes in outstanding claims/ benefits including IBNR | 19,208 | -4,787 | |
| Changes in other technical reserves | 26,211 | 7,207 | |
| Changes in other reserves | -684 | 766 | |
| Net claims/ benefits incurred | 437,377 | 347,905 | |
| Policy acquisition costs | 75,100 | 30,632 | |
| General and administrative expenses, insurance/ takaful operations | 80,065 | 73,469 | |
| Other underwriting expenses | 422 | 5,733 | |
| Other cost and expenses | 1,784 | -4,354 | |
| Total cost and expenses | 594,748 | 453,385 | |
| Surplus (deficit) for period from insurance/ takaful operations | -104,010 | 4,558 | |
| Shareholders appropriation from insurance/ takaful operations surplus (deficit) | -104,010 | 4,102 | |
| Net result for period from insurance/ takaful operations after shareholders appropriation | 0 | 456 | |
| Policyholders share of accumulated surplus, at end of period | 0 | 456 |
| [300300] Statement of shareholders operations, nature of expense |
| Start Date | 2021-01-01 | 2020-01-01 | Note No. |
|---|---|---|---|
| End Date | 2021-12-31 | 2020-12-31 | |
| Statement of shareholders operations [abstract] | |||
| Profit (loss) [abstract] | |||
| Income (loss) from continuing operations [abstract] | |||
| Shareholders appropriation of surplus (deficit) transferred from insurance/ takaful operations | -104,010 | 4,102 | |
| Revenue [abstract] | |||
| Commission/ profit on deposits | 402 | 510 | |
| Investment income | 2,004 | 2,056 | |
| Total revenue | 2,406 | 2,566 | |
| Expenses [abstract] | |||
| General and administrative expenses, shareholders operations | 2,404 | 3,122 | |
| Total expenses | 2,404 | 3,122 | |
| Income (loss) from continuing operations before zakat and income tax | -104,008 | 3,546 | |
| Zakat expenses on continuing operations for period | 10,576 | 4,463 | |
| Profit (loss) from continuing operations | -114,584 | -917 | |
| Profit (loss) for the period | -114,584 | -917 | |
| Profit (loss), attributable to [abstract] | |||
| Profit (loss), attributable to saudi shareholders of company | -114,584 | -917 | |
| Earnings per share [abstract] | |||
| Basic earnings (loss) per share [abstract] | |||
| Basic earnings (loss) per share from continuing operations | -8.13 | -0.07 | |
| Total basic earnings (loss) per share | -8.13 | -0.07 | |
| Diluted earnings (loss) per share [abstract] | |||
| Diluted earnings (loss) per share from continuing operations | -8.13 | -0.07 | |
| Total diluted earnings (loss) per share | -8.13 | -0.07 | |
| Weighted average number of equity shares outstanding | 14100000 | 14100000 | |
| Share closing price at the last trading day of financial year (in numbers) | 23.6 | 62.8 |
| [300400] Statement of other comprehensive income, before tax, insurance operations |
| Start Date | 2021-01-01 | 2020-01-01 | Note No. |
|---|---|---|---|
| End Date | 2021-12-31 | 2020-12-31 | |
| Statement of other comprehensive income, before tax [abstract] | |||
| Net result for period from insurance/ takaful operations after shareholders appropriation | 0 | 456 | |
| Total comprehensive income (loss) for period | 0 | 456 |
| [300500] Statement of other comprehensive income, before tax, shareholders operations |
| Start Date | 2021-01-01 | 2020-01-01 | Note No. |
|---|---|---|---|
| End Date | 2021-12-31 | 2020-12-31 | |
| Statement of other comprehensive income, before tax [abstract] | |||
| Statement of comprehensive income [abstract] | |||
| Profit (loss) for the period | -114,584 | -917 | |
| Total comprehensive income (loss) for period | -114,584 | -917 | |
| Total comprehensive income (loss) attributable to [abstract] | |||
| Total comprehensive income (loss), attributable to saudi shareholders of company | -114,584 | -917 |
| [300600] Statement of cash flows, indirect method, insurance operations |
| Start Date | 2021-01-01 | 2020-01-01 | Note No. |
|---|---|---|---|
| End Date | 2021-12-31 | 2020-12-31 | |
| Statement of cash flows, indirect method [abstract] | |||
| Statement of cash flows, insurance/ takaful operations [abstract] | |||
| Cash flows from (used in) operating activities, insurance/ takaful operations [abstract] | |||
| Net result for period from insurance/ takaful operations after shareholders appropriation | 0 | 456 | |
| Adjustments to reconcile net income to net cash from insurance/ takaful operations after shareholders appropriation | |||
| Adjustments for depreciation, insurance/ takaful operations cash flow | 1,182 | 1,276 | |
| Adjustments for allocated depreciation from shareholders operations | 2,011 | 2,093 | |
| Adjustments for unrealised (gains) losses on investments held as fair value through statement of income | 1,783 | 1,270 | |
| Adjustments for employees end of service benefits | 2,184 | 2,315 | |
| Adjustments for allowance for doubtful receivables | 1,784 | -4,354 | |
| Total adjustments to reconcile net income to net cash from insurance/ takaful operations after shareholders appropriation | 8,944 | 2,600 | |
| Changes in operating assets and liabilities [abstract] | |||
| Adjustments for decrease (increase) in premium receivables, net | -1,561 | -6,144 | |
| Adjustments for increase (decrease) in outstanding claims including IBNR | 20,733 | -1,174 | |
| Adjustments for increase (decrease) in reinsurers/ retakaful balance payable | 8,088 | 191 | |
| Adjustments for increase (decrease) in retrocession balance payable | 10,647 | 8,636 | |
| Adjustments for increase (decrease) in accrued expenses and other liabilities | -37,101 | 13,032 | |
| Adjustments for increase (decrease) in accrued commission income | -165 | 87 | |
| Adjustments for decrease (increase) in reinsurers/ retakaful share of outstanding claims, net | -1,525 | -3,613 | |
| Adjustments for decrease (increase) in deferred policy acquisition costs | -12,394 | -17,502 | |
| Adjustments for decrease (increase) in advances and other receivables | 5,165 | -16,845 | |
| Adjustments for movement in gross unearned premiums/ contributions | 37,275 | 10,109 | |
| Adjustments for reinsurance/ retakaful share of unearned premiums/ contributions | -7,310 | -6,070 | |
| Adjustment for changes in other reserves | 25,527 | 8,205 | |
| Adjustments for other changes in operating assets and liabilities, insurance/ takaful operations cash flow | -4,113 | -582 | |
| Total changes in operating assets and liabilities | 43,266 | -11,670 | |
| Net cash flows from (used in) insurance/ takaful operations | 52,210 | -8,614 | |
| Net cash flows from (used in) operating activities, insurance/ takaful operations | 52,210 | -8,614 | |
| Cash flows from (used in) investing activities, insurance/ takaful operations [abstract] | |||
| Time (Murabaha) deposits, insurance/ takaful operations cash flow | -63,036 | ||
| Proceeds from sales of investments, insurance/ takaful operations cash flow | 19,589 | ||
| Purchase of property and equipment, insurance/ takaful operations cash flow | 5,887 | 6,609 | |
| Net cash flows from (used in) investing activities, insurance/ takaful operations | -68,923 | 12,980 | |
| Cash flows from (used in) financing activities, insurance/ takaful operations [abstract] | |||
| Adjustments for decrease (increase) in due from shareholders operations | 0 | 0 | |
| Adjustments for increase (decrease) in due to shareholders operations | 0 | 0 | |
| Due to related party, insurance/ takaful operations cash flow | 0 | 0 | |
| Surplus paid to policyholders | 0 | 0 | |
| Payments to acquire or redeem treasury shares | 0 | 0 | |
| Other inflows (outflows) of cash classified as financing activities, insurance/ takaful operations cash flow | 0 | ||
| Net cash flows from (used in) financing activities, insurance/ takaful operations | 0 | 0 | |
| Increase (decrease) in cash and cash equivalents before effect of exchange rate changes | -16,713 | 4,366 | |
| Net increase (decrease) in cash and cash equivalents | -16,713 | 4,366 | |
| Cash and cash equivalents at beginning of period | 69,686 | 65,320 | |
| Cash and cash equivalents at end of period | 52,973 | 69,686 |
| [300700] Statement of cash flows, indirect method, shareholders operations |
| Start Date | 2021-01-01 | 2020-01-01 | Note No. |
|---|---|---|---|
| End Date | 2021-12-31 | 2020-12-31 | |
| Statement of cash flows, indirect method [abstract] | |||
| Statement of cash flows [abstract] | |||
| Cash flows from (used in) operating activities [abstract] | |||
| Net profit (loss) for period [abstract] | |||
| Income (loss) from continuing operations before zakat and income tax | -104,008 | 3,546 | |
| Net profit (loss) for period (before zakat expenses and income tax) | -104,008 | 3,546 | |
| Changes in operating assets and liabilities [abstract] | |||
| Adjustments for increase (decrease) in accrued expenses and other liabilities, shareholders cash flow | 31,952 | 697 | |
| Adjustments for decrease (increase) in prepayments and other assets, shareholders assets | -877 | 127 | |
| Total changes in operating assets and liabilities | 31,075 | 824 | |
| Net cash flows from (used in) operations | -72,933 | 4,370 | |
| Zakat expenses | 2,318 | 1,941 | |
| Net cash flows from (used in) operating activities | -75,251 | 2,429 | |
| Cash flows from (used in) investing activities [abstract] | |||
| Proceeds from disposal of shares under long-term incentive plan (LTIP) | 55,663 | ||
| Proceeds from disposal of available-for-sale investments | 5,000 | ||
| Purchase of held-to-maturity investments | 0 | ||
| Proceeds from disposal of held-to-maturity investments | 0 | ||
| Proceeds form Murabaha/ time deposits matured during the period | 0 | ||
| Purchase of term deposits investments | 0 | 0 | |
| Acquistion of murabaha/ time deposits | 0 | 0 | |
| Proceeds from redemption of term deposits investments | 0 | 0 | |
| Amount paid for statutory deposit | 0 | ||
| Purchase of property and equipment | 0 | 0 | |
| Proceeds from disposal of property and equipment | 0 | ||
| Cash flows from losing control of subsidiaries or other businesses | 0 | 0 | |
| Cash flows used in obtaining control of subsidiaries or other businesses | 0 | 0 | |
| Other cash receipts from sales of equity or debt instruments of other entities | 0 | ||
| Other inflows (outflows) of cash | 0 | ||
| Net cash flows from (used in) investing activities | 0 | 60,663 | |
| Cash flows from (used in) financing activities [abstract] | |||
| Proceeds from issuing shares | 0 | 0 | |
| Payment of transaction costs | 0 | 0 | |
| Payment of due to others | 0 | 0 | |
| Proceeds from issuing other equity instruments | 0 | 0 | |
| Payments to acquire or redeem entity's shares | 0 | 0 | |
| Payments of other equity instruments | 0 | 0 | |
| Proceeds from borrowings | 0 | 0 | |
| Repayments of borrowings | 0 | 0 | |
| Payments of finance lease liabilities | 0 | 0 | |
| Dividends paid | 0 | 0 | |
| Other inflows (outflows) of cash | 0 | 0 | |
| Net cash flows from (used in) financing activities | 0 | 0 | |
| Increase (decrease) in cash and cash equivalents before effect of exchange rate changes | -75,251 | 63,092 | |
| Net increase (decrease) in cash and cash equivalents | -75,251 | 63,092 | |
| Cash and cash equivalents at beginning of period | 75,251 | 12,159 | |
| Cash and cash equivalents at end of period | 0 | 75,251 |
| [300800] Statement of changes in equity |
|   | Share capital [member] | Share premium [member] | Statutory reserve [member] | General reserve [member] | Fair value reserve on investments, shareholders equity [member] | Retained earnings (accumulated losses) [member] | Treasury shares [member] | Other reserves [member] | Reserve of disposal group held for distribution/ sale [member] | Share based payments reserve [member] | Other equity interest [member] | Equity attributable to owners of parent [member] | Non-controlling interests [member] | Total equity [member] | Note No. | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Start Date | 2021-01-01 | 2020-01-01 | 2021-01-01 | 2020-01-01 | 2021-01-01 | 2020-01-01 | 2021-01-01 | 2020-01-01 | 2021-01-01 | 2020-01-01 | 2021-01-01 | 2020-01-01 | 2021-01-01 | 2020-01-01 | 2021-01-01 | 2020-01-01 | 2021-01-01 | 2020-01-01 | 2021-01-01 | 2020-01-01 | 2021-01-01 | 2020-01-01 | 2021-01-01 | 2020-01-01 | 2021-01-01 | 2020-01-01 | 2021-01-01 | 2020-01-01 | |
| End Date | 2021-12-31 | 2020-12-31 | 2021-12-31 | 2020-12-31 | 2021-12-31 | 2020-12-31 | 2021-12-31 | 2020-12-31 | 2021-12-31 | 2020-12-31 | 2021-12-31 | 2020-12-31 | 2021-12-31 | 2020-12-31 | 2021-12-31 | 2020-12-31 | 2021-12-31 | 2020-12-31 | 2021-12-31 | 2020-12-31 | 2021-12-31 | 2020-12-31 | 2021-12-31 | 2020-12-31 | 2021-12-31 | 2020-12-31 | 2021-12-31 | 2020-12-31 | |
| Statement of changes in equity [line items] | |||||||||||||||||||||||||||||
| Equity balance at beginning of period (before adjustments) | 141,000 | 200,000 | -1,431 | -59,514 | 7,126 | 3,973 | 146,695 | 144,459 | |||||||||||||||||||||
| Equity balance at beginning of period (after adjustments) | 141,000 | 200,000 | -1,431 | -59,514 | 7,126 | 3,973 | 146,695 | 144,459 | |||||||||||||||||||||
| Changes in equity [abstract] | |||||||||||||||||||||||||||||
| Comprehensive income [abstract] | |||||||||||||||||||||||||||||
| Net profit (loss) for period | -114,584 | -917 | -114,584 | -917 | |||||||||||||||||||||||||
| Total comprehensive income (loss) for period | -114,584 | -917 | -114,584 | -917 | |||||||||||||||||||||||||
| Other miscellaneous changes in equity | -59,000 | 59,000 | 1,462 | 3,153 | 1,462 | 3,153 | |||||||||||||||||||||||
| Total changes in equity | -59,000 | -114,584 | 58,083 | 1,462 | 3,153 | -113,122 | 2,236 | ||||||||||||||||||||||
| Equity balance at end of period | 141,000 | 141,000 | -116,015 | -1,431 | 8,588 | 7,126 | 33,573 | 146,695 | |||||||||||||||||||||
| [400100] Notes forming part of accounts |
|   | English [member] | Note No. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Start Date | 2021-01-01 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| End Date | 2021-12-31 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Notes forming part of accounts [line items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Disclosure of notes and other explanatory information [text block] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Disclosure of general information about reporting entity [abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Disclosure of basis of preparation of financial statements [text block] | BASIS OF PREPARATION Statement of complianceThese financial statements of the Company have been prepared in accordance with International Financial Reporting Standards (IFRSs) that are endorsed in the Kingdom of Saudi Arabia and other standards and pronouncements endorsed by the Saudi Organization for Chartered and Professional Accountants (“SOCPA”) and the Regulations for Companies in the Kingdom of Saudi Arabia.Basis of preparation and measurementThe Company incurred loss for the year ended 31 December, 2021 of SAR 114.5 million (2020: SAR 461 thousand) and, as of that date, the accumulated losses of the Company exceeded half of its share capital and the solvency margin of the Company reached to -119 % (31 December, 2020: 100%). The reason for these losses is primarily attributed to unexpected increase in the number of motor accidents and the average motor claims cost (including policy acquisition cost) across the Kingdom of Saudi Arabia. Owing to these factors, the Company has recorded premium deficiency reserve and claims incurred but not reported as at year end for motor line of business, amounting to SAR 35. 7 million (2020: SAR 4.4 million) and SAR 53.1 million (2020: SAR 42.3 million) respectively, along with its policy acquisition cost of SAR 62.3 million during the current year compared to SAR 20.2 million during the compared period.These events and conditions indicate material uncertainties on the Company’s ability to continue as going concern Considering the above, various strategic options including capital restructuring were considered by the Board of Directors to ensure appropriateness of the Company’s going concern assumption as at year end. Amongst such strategic options, the Board of Directors approved a business plan for 2022 on 21 December, 2021. The plan is based on the adjusted prices for motor line of business for improving the net premium written and control over expenses and loss ratios to meet the requirements of Article 68(c) of SAMA Implementations Regulations for Insurance Companies. Moreover, the Shareholders, in an extraordinary general assembly meeting held on 29 December 2021, resolved to increase the share capital by SAR 150 million (representing 15 million shares) by way of right issue to further strength its liquidity position. The above right issue process was completed in tranches subsequent to the year end and the resulting total proceeds from the right issue was received on 7 March 2022 (Refer to Note 23).The above plan demonstrates that the Company will be able to continue as a going concern for foreseeable future. Accordingly, the financial statements have been prepared on a going concern basis. NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER, 2021 2 (b) BASIS OF PREPARATION-(CONTINUED)Basis of preparation and measurement-(Continued)These financial statements have been prepared under going concern basis and historical cost convention except for the measurement at fair value of investments held as fair value through Other comprehensive income and employees’ defined benefit obligations which is recognized at the present value of future obligations using the projected unit credit method. The Company’s statement of financial position is not presented using a current/non-current classification. However, the following balances would generally be classified as current: cash and cash equivalents, short term deposits, premiums and reinsurers’ receivable - net, reinsurers’ share of unearned premiums, deferred policy acquisition costs, deferred excess of loss premiums, prepayments and other assets, policyholders payable, reinsurers balances payable, accrued and other liabilities, unearned premiums, unearned reinsurance commission, outstanding claims, claims incurred but not reported, premium deficiency reserve, other technical reserves and Zakat and income tax payable. All other financial statement line items would generally be classified as non-current, unless stated otherwise. The statement of financial position, statements of income, statement of other comprehensive income and cash flows of the insurance operations and shareholders’ operations which are presented in Note 29 of the financial statements have been provided as supplementary financial information and to comply with the requirements of the guidelines issued by SAMA implementing regulations. SAMA implementing regulations require the clear segregation of the assets, liabilities, income and expenses of the insurance operations and the shareholders’ operations. Accordingly, the statements of financial position, statements of income, statement of other comprehensive income and cash flows prepared for the insurance operations and shareholders operations as referred to above, reflect only the assets, liabilities, income, expenses and comprehensive gains or losses of the respective operations. (Note 29).The Company presents its statement of financial position in order of liquidity. As required by the Saudi Arabian Insurance Regulations, the Company maintains separate books of accounts for “Insurance Operations” and “Shareholders’ Operations” and presents the financial statements accordingly (Note29). Assets, liabilities, revenues and expenses clearly attributable to either activity are recorded in the respective accounts. The basis of allocation of expenses from joint operations is determined and approved by the management and the Board of Directors.In preparing the Company-level financial statements in compliance with IFRS, the balances and transactions of the insurance operations are amalgamated and combined with those of the shareholders’ operations. Inter-operation balances and transactions, if any, are eliminated in full. The accounting policies adopted for the insurance operations and shareholders’ operations are uniform for like transactions and events in similar circumstances.As per the by-laws of the Company, surplus arising from the Insurance Operations is distributed as follows: Transfer to Shareholders’ operationsTransfer to Policyholders’ operations 90%10%100% In case of deficit arising from the insurance operations, the entire deficit is allocated and transferred to the shareholders’ operations in full.In accordance with Article 70 of SAMA implementing regulations, the Company proposes to distribute, subject to the approval of SAMA, its annual netpolicyholders’ surplus directly to policyholders at a time, and according to criteria, as set by its Board of Directors. (c)d)e) Functional and presentation currencyThese financial statements have been presented in Saudi Arabian Riyals (“SAR”), which is also the functional currency of the Company. All financial information presented in SAR has been rounded to the nearest thousands, except where otherwise indicated.Fiscal yearThe Company’s fiscal year is aligned with the calendar year i.e. it begins at 1 January and ends at 31 December.Critical accounting judgments, estimates and assumptionsThe preparation of the financial statements requires the use of estimates and judgments that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting year. Although these estimates and judgments are based on management’s best knowledge of current events and actions, actual results ultimately may differ from those estimates. NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER, 20212 BASIS OF PREPARATION-(CONTINUED)e) Critical accounting judgments, estimates and assumptions-(Continued)Estimates and judgments are continually evaluated and based on historical experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances.In preparing these financial statements, the significant judgments made by management in applying the Company’s accounting policies and the key sources of estimation uncertainty including the risk management policies were the same as those that applied to the annual financial statements as at and for the year ended 31 December, 2020. However, the Company has reviewed the key sources of estimation uncertainties disclosed in the last annual financial statements against the backdrop of the COVID-19 pandemic. For further details, please see note 31 to these financial statements. Management will continue to assess the situation and reflect any required changes in future reporting periods.Estimates and judgments are continually evaluated and based on historical experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances.Following are the accounting judgments and estimates that are critical in preparation of these financial statements:i) The ultimate liability arising from claims made under insurance contractsThe estimation of the ultimate liability arising from claims made under insurance contracts is the Company’s most critical accounting estimate. There are several sources of uncertainty that need to be considered in the estimate of the liability that the Company will ultimately pay for such claims. Estimates are made at the end of the reporting year both for the expected ultimate cost of claim reported and for the expected ultimate costs of claims incurred but not reported (“IBNR”). Liabilities for unpaid reported claims are estimated using the input of assessments for individual cases reported to the Company. At the end of each reporting year, prior year claims estimates are reassessed for adequacy and changes are made to the provision.The provision for claims incurred but not reported (IBNR) is an estimation of claims which are expected to be reported subsequent to the date of statement of financial position, for which the insured event has occurred prior to the date of statement of financial position. The primary technique adopted by management in estimating the cost of notified and IBNR claims is that of using the past claims settlement trends to predict future claims settlement trends. A range of methods such as Chain Ladder Method, Bornhuetter-Ferguson Method and Expected Loss Ratio Method are used by the actuaries to determine these provisions. The actuary had also used a segmentation approach including analyzing cost per member per year for medical line of business. Underlying these methods are a number of explicit or implicit assumptions relating to the expected settlement amount and settlement patterns of claims.ii) Impairment of financial assetsThe Company determines that financial assets are impaired when there has been a significant or prolonged decline in the fair value of the financial assets below its cost. The determination of what is significant or prolonged requires judgment. A period of 12 months or longer is considered to be prolonged and a decline of 30% from the original cost is considered significant as per the Company’s policy. In making this judgment, the Company evaluates among other factors, the normal volatility in share price, the financial health of the investee, industry and sector performance, changes in technology, and operational and financing cash flows.iii) Impairment of receivablesA provision for impairment of receivables is established when there is objective evidence that the Company will not be able to collect all amounts due according to the original terms of the receivables. Significant financial difficulties of the debtor, probability that the debtor will enter into bankruptcy or financial reorganization, and default or delinquency in payments are considered indicators that the receivable is impaired. The Company is exposed to disputes with, and the possibility of defaults by, its reinsurers. The Company monitors on a quarterly basis the evolution of disputes with and the strength of its reinsurers. NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER, 20212 BASIS OF PREPARATION-(CONTINUED)e) Critical accounting judgments, estimates and assumptions-(Continued)iv) Deferred policy acquisition costsCertain acquisition costs related to the sale of new policies are recorded as deferred acquisition costs (DAC) and are amortized in the statement of insurance operations and accumulated surplus over the related period of policy coverage. If the assumptions relating to future profitability of these policies are not realized, the amortization of these costs could beaccelerated and this may also require additional impairment write-offs in the statement of incomeV) Premium deficiency reserveEstimation of premium deficiency reserve is highly sensitive to a number of assumptions as to future events and conditions. It is based on an expected loss ratio for the unexpired portion of the risks for written policies. To arrive at the estimate of the expected loss ratio, the Company’s actuarial team and the independent actuary, consider the claims and premiums relationship which is expected to apply on a monthly basis, and ascertain, at the end of the financial year, whether a premium deficiency reserve is required.vi) Fair value of financial instrumentsThe fair value for financial instruments traded in active markets at the reporting date are based on quoted prices for marketable securities or estimated fair values. The fair value of commission-bearing items is estimated based on discounted cash flows using commission for items with similar terms and risk characteristics.The fair value of financial instruments where no active market exists or where quoted prices are not otherwise available are determined by using valuation techniques. In these cases, the fair values are estimated from observable data in respect of similar financial instruments or using models. Where market observable inputs are not available, they are estimated based on appropriate assumptions. Where valuation techniques (for example, models) are used to determine fair values, they are validated and periodically reviewed by qualified personnel independent of those that sourced them. All models are certified before they are used, and models are calibrated to ensure that outputs reflect actual data and comparative market prices. To the extent practical, models use only observable data; however, areas such as credit risk (both own credit risk and counterparty risk), volatilities and correlations require management to make estimates.vii) Useful lives of property and equipment and intangible assetsThe Company's management determines the estimated useful lives of its property and equipment and intangible assets for calculating depreciation / amortization. These estimates are determined after considering the expected usage of the assets or physical wear and tear. Management reviews the residual value and useful lives annually and future depreciation / amortization charge would be adjusted where the management believes the useful lives differ from previous estimates.viii) Going concernThe Company’s management has made an assessment of its ability to continue as a going concern and is satisfied that it has the resources to continue in business for the foreseeable future. (Note 2(b))ix) Employees’ terminal benefitsThe employees’ terminal benefits obligation is determined by an independent actuary using the projected unit credit method as recommended in IAS 19 “Employee benefits”. The present value of the defined benefit obligation is determined by discounting the estimated cash outflows using interest rates of sovereign debt instruments that are denominated in Saudi Riyals and have maturity periods approximating that of the gratuity liability. 2 BASIS OF PREPARATION-(CONTINUED)e) Critical accounting judgments, estimates and assumptions-(Continued)ix) Employees’ terminal benefits -(Continued)The present value of the defined benefit obligation depends on several factors that are determined by the actuary using assumptions such as discount rate, expected future salary increases, mortality rates and staff turnover etc. These estimates are subject to significant uncertainty due to their long-term nature and are reviewed at each reporting date.3 SIGNIFICANT ACCOUNTING POLICIESThe accounting policies adopted by the Company for the preparation of these financial statements are in accordance with IFRS as endorsed in the KSA and are consistent with those used for the preparation of the annual financial statements for the year ended 31 December 2021 and new amended IFRS and IFRS Interpretations Committee Interpretations (IFRIC) as mentioned in note 3(a) which had no significant impact on the financial position or financial performance of the Company.The accounting policies used in the preparation of the financial statements are consistent with those followed in the preparation of the Company’sannual financial statements for the year ended 31 December 2020, except where otherwise stated.A STANDARDS, INTERPRETATIONS, AND AMENDMENTS TO EXISTING STANDARDSThe new and amended standards and interpretations that are issued, but not yet effective, up to the date of Company’s financial statements are disclosed below. The Company intends to adopt these new and amended standards and interpretations, if applicable, when they become effective(i) New standards, interpretations and amendments not yet effectiveThere are a number of standards, amendments to standards, and interpretations which have been issued by the IASB that are effective in future accounting periods that the Company has decided not to adopt early. The most significant of these are as follows: IFRS Summary Effective Annual Improvements to IFRS: 2018-2020Cycle In May 2020, the IASB issued minor amendments to IFRS 1 First-time Adoption ofInternational Financial Reporting Standards, IFRS 9 Financial Instruments, IAS 41Agriculture and the Illustrative Examples accompanying IFRS 16 Leases 01 January, 2022 Reference to theConceptualFramework In May 2020, the IASB issued amendments to IFRS 3.11, which update a reference to theConceptual Framework for Financial Reporting without changing the accounting 01 January, 2022 Amendments to IFRS 3 requirements for business combinations. The amendments introduce an exception to the general recognition requirement for liabilities and contingent liabilities acquired in a business combination that is within the scope of IAS 37 Provisions, Contingent Liabilities and Contingent Assets and IFRIC 12 Service Concession arrangements. Property, Plant and Equipment: Proceeds before Intended Use (Amendments to IAS16)Onerous Contracts— Cost of Fulfilling a Contract Amendments to IAS 37 In May 2020, the IASB issued amendments to IAS 16, which prohibit a company from deducting amounts received from selling items produced while the company is preparing the asset for its intended use from the cost of property, plant and equipment. Instead, a company will recognise such sales proceeds and any related costs in profit or loss.In May 2020, the IASB issued amendments to IAS 37.68A, which specify the costs a company includes when assessing whether a contract will be loss-making and is therefore recognised as an onerous contract. These amendments are expected to result in more contracts being accounted for as onerous contracts because they increase the scope of costs that are included in the onerous contract assessment. 01 January, 202201 January, 2022 IFRS 4IFRS 9IFRS 17 Insurance Contracts-Amendments regarding the expiry date of the deferral approach 01 January, 2022Financial Instruments See note belowInsurance contracts See note below NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) | 2 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Disclosure of general information about reporting entity's subsidiaries and their principal activities [text block] | ORGANIZATION AND PRINCIPAL ACTIVITIESAllied Cooperative Insurance Group (“the Company” or “ACIG”) is a Saudi Joint Stock Company incorporated in the Kingdom of Saudi Arabia under Commercial Registration No. 1010417178 dated Shabaan 9,1428H, corresponding to 22 August, 2007. The registered office of the Company is situated at Hteen district, Prince Turki bin Abdulaziz Road, Riyadh.The activities of the Company are to transact cooperative insurance operations and related activities in the Kingdom of Saudi Arabia. On 4 April, 2009, the Company received a license from the Saudi Central Bank (“SAMA”) to engage in insurance in Saudi Arabia. The Company commenced its commercial operations on 1 July, 2009. The Company was listed on the Saudi Stock Exchange (Tadawul) on 27 August, 2007.The Company has 3 registered branches as set out below: BranchBranch of ACIG Branch of ACIG Branch of ACIG Commercial RegistrationNumber205104367158550351504030204059 Place of issuanceAl Khobar Khamis Mushayt Jeddah Date12 Ramadan 1439 H12 Ramadan 1439 H12 Ramadan 1439 H | 1 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Disclosure of summary of significant accounting policies [abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Disclosure of summary of significant accounting policies, general comment [text block] | 3 SIGNIFICANT ACCOUNTING POLICIES-(CONTINUED) A STANDARDS, INTERPRETATIONS, AND AMENDMENTS TO EXISTING STANDARDS-(CONTINUED) (i) New standards, interpretations and amendments not yet effective-(Continued) IFRS Summary Effective Classification of Liabilities
as Current or Non- such conditions and to defer the effective date of the 2020 amendment by at least one year to 1 current (Amendment to IAS 1)
The amendments require to defer settlement of the liability for at least twelve months after the reporting period to exist at the end of the reporting period and / or that right to defer settlement for at least twelve months after the reporting period is also subject to entity’s compliance with specified conditions. The Amendment has provided clarification on the meaning of ‘settlement’ for the purpose of classification of a liability. (ii) New standards, interpretations and amendments effective in the current year IFRS Summary Effective date Interest Rate Benchmark Reform – Phase 2 Amendments to IFRS 9 and IAS 39 Covid-19-Related Rent Concessions beyond 30 June 2021
Additionally, the standards were amended to require change from IBOR to alternative benchmark rate that is accounted for by updating the effective interest rate In March 2021, IASB issued an amendment to IFRS 16 which extended the COVID-19 related 01 April , 2021 rent concessions beyond 30 June 2021. This amendment is applicable from annual reporting period beginning on or after 1 April 2021. Earlier application permitted, including in financial statements not authorized for issue at 31 March 2021. IFRS 9 - Financial Instruments This standard was published on 24 July 2014 and has replaced IAS 39. The new standard addresses the following items related to financial instruments: a) Classification and measurement: IFRS 9 uses a single approach to determine whether a financial asset is measured at amortized cost, fair value through other comprehensive income or fair value through profit or loss. A financial asset is measured at amortized cost if both: the asset is held within a business model whose objective is to hold assets in order to collect contractual cash flows; and the contractual terms of the financial asset give rise on specified dates to cash flows that are solely payments of principal and interest on the principal amount outstanding (“SPPI”). The financial asset is measured at fair value through other comprehensive income and realized gains or losses would be recycled through profit or loss upon sale, if both conditions are met: the asset is held within a business model whose objective is to hold assets in order to collect contractual cash flows and for sale; and the contractual terms of cash flows are SPPI Debt financial assets not meeting either of these categories are measured at fair value through profit or loss. Additionally, at initial recognition, an entity can use the option to designate a financial asset, both debt and equity instrument at fair value through profit or loss if doing so eliminates or significantly reduces an accounting mismatch For equity instruments that are not held for trading, an entity can also make an irrevocable election to present in other comprehensive income subsequent changes in the fair value of the instruments (including realized gains and losses), dividends being recognized in statement of income. Additionally, for financial liabilities that are designated as at fair value through profit or loss, the amount of change in the fair value of the financial liability that is attributable to changes in the credit risk of that liability is recognized in other comprehensive income, unless the recognition of the effects of changes in the liability’s credit risk in other comprehensive income would create or enlarge an accounting mismatch in statement of income. IFRS 9 - Financial Instruments-"(Continued)" b) Impairment: The impairment model under IFRS 9 reflects expected credit losses, as opposed to incurred credit losses under IAS 39. Under the IFRS 9 approach, it is no longer necessary for a credit event to have occurred before credit losses are recognized. Instead, an entity always accounts for expected credit losses and changes in those expected credit losses. The amount of expected credit losses is updated at each reporting date to reflect changes in credit risk since initial recognition. c) Hedge Accounting IFRS 9 introduces new requirements for hedge accounting that align hedge accounting more closely with Risk Management. The requirements establish a more principles-based approach to the general hedge accounting model. The amendments apply to all hedge accounting with the exception of portfolio fair value hedges of interest rate risk (commonly referred to as “fair value macro hedges”). For these, an entity may continue to apply the hedge accounting requirements currently in IAS 39. This exception was granted largely because the IASB is addressing macro hedge accounting as a separate project. Effective date: The published effective date of IFRS 9 was 1 January 2018. However, amendments to IFRS 4 – Insurance Contracts: Applying IFRS 9 – Financial Instruments with IFRS 4 – Insurance Contracts, published on 12 September 2016, changes the existing IFRS 4 to allow entities issuing insurance contracts within the scope of IFRS 4 to mitigate certain effects of applying IFRS 9 before the IASB’s new insurance contract standard (IFRS 17 – Insurance Contracts) becomes effective. The amendments introduce two alternative options: 1) Apply a temporary exemption from implementing IFRS 9 until the earlier of a. the effective date of a new insurance contract standard; or b. annual reporting periods beginning on or after 1 January 2021. On 17 March 2020, the International Accounting Standards Board (“IASB”) decided to extend the effective date of IFRS 17 and the IFRS 9 temporary exemption in IFRS 4 from 1 January 2021 to 1 January 2023. Additional disclosures related to financial assets are required during the deferral period. This option is only available to entities whose activities are predominately connected with insurance and have not applied IFRS 9 previously; or 2. Adopt IFRS 9 but, for designated financial assets, remove from profit or loss the effects of some of the accounting mismatches that may occur before the new insurance contract standard is implemented. During the year, additional disclosures are required. The Company has performed a detailed assessment beginning 1 January 2017: (1) The carrying amount of the Company’s liabilities arising from contracts within the scope of IFRS 4 (including deposit components or embedded derivatives unbundled from insurance contracts) were compared to the total carrying amount of all its liabilities; and (2) the total carrying amount of the company’s liabilities connected with insurance were compared to the total carrying amount of all its liabilities. Based on these assessments the Company determined that it is eligible for the temporary exemption. Consequently, the Company has decided to defer the implementation of IFRS 9 until the effective date of the new insurance contracts standard. Disclosures related to financial assets required during the deferral period are included in the Company’s annual financial statements for the year ended 31 December 2021. Impact assessment Overall, the Company expects some impact of applying the impairment requirements of IFRS 9 on the financial statements of the Company. However, the impact of the same is not expected to be significant. At present it is not possible to provide reasonable estimate of the effects of application of this new standard as the Company is yet to perform a detailed review. IFRS 17 - “Insurance Contracts” Overview This standard has been published on 18 May 2017, it establishes the principles for the recognition, measurement, presentation and disclosure of insurance contracts and supersedes IFRS 4 – Insurance contracts The new standard applies to insurance contracts issued, to all reinsurance contracts and to investment contracts with discretionary participating features provided the entity also issues insurance contracts. It requires to separate the following components from insurance contracts: a. embedded derivatives, if they meet certain specified criteria; b. distinct investment components; and c. any promise to transfer distinct goods or non-insurance services. These components should be accounted for separately in accordance with the related standards (IFRS 9 and IFRS 15). NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER, 2021 3SIGNIFICANT ACCOUNTING POLICIES-(CONTINUED) ASTANDARDS, INTERPRETATIONS, AND AMENDMENTS TO EXISTING STANDARDS-(Continued) IFRS 17 - “Insurance Contracts”-(Continued) Measurement In contrast to the requirements in IFRS 4, which permitted insurers to continue to use the accounting policies for measurement purposes that existed prior to January 2015, IFRS 17 provides the following different measurement models: The General model is based on the following “building blocks”: a. the fulfilment cash flows (FCF), which comprise: probability-weighted estimates of future cash flows; an adjustment to reflect the time value of money (i.e. discounting) and the financial risks associated with those future cash flows; and a risk adjustment for non-financial risk. b. the Contractual Service Margin (CSM). The CSM represents the unearned profit for a group of insurance contracts and will be recognized as the entity provides services in the future. The CSM cannot be negative at inception; any net negative amount of the fulfilment cash flows at inception will be recorded in profit or loss immediately. At the end of each subsequent reporting period the carrying amount of a group of insurance contracts is remeasured to be the sum of: the liability for remaining coverage, which comprises the FCF related to future services and the CSM of the group at that date; and the liability for incurred claims, which is measured as the FCF related to past services allocated to the group at that date. The CSM is adjusted subsequently for changes in cash flows related to future services but the CSM cannot be negative, so changes in future cash flows that are greater than the remaining CSM are recognized in profit or loss. Interest is also accreted on the CSM at rates locked in at initial recognition of a contract (i.e. discount rate used at inception to determine the present value of the estimated cash flows). Moreover, the CSM will be released into profit or loss based on coverage units, reflecting the quantity of the benefits provided and the expected coverage duration of the remaining contracts in the group. The Variable Fee Approach (VFA) is a mandatory model for measuring contracts with direct participation features (also referred to as ‘direct participating contracts’). This assessment of whether the contract meets these criteria is made at inception of the contract and not reassessed subsequently. For these contracts, the CSM is also adjusted in addition to adjustment under general model; I. changes in the entity’s share of the fair value of underlying items; and II. changes in the effect of the time value of money and financial risks not relating to the underlying items. Effective date The Company intends to apply the Standard on its effective date i.e. 1 January 2023. The IASB issued an Exposure Draft Amendments to IFRS 17 proposing certain amendments to IFRS 17 during June 2019 and received comments from various stakeholders. On 17 March 2020, the IASB completed its discussions on the amendments to IFRS 17 Insurance Contracts that were proposed for public consultation in June 2019. It decided that the effective date of the Standard will be deferred to annual reporting periods beginning on or after 1 January 2023. The IASB expects to issue the amendments to IFRS 17 in the second quarter of 2020. Earlier application is permitted if both IFRS 15 – Revenue from Contracts with Customers and IFRS 9 – Financial Instruments have also been applied. Transition Retrospective application is required. However, if full retrospective application for a group of insurance contracts is impracticable, then the entity is required to choose either a modified retrospective approach or a fair value approach Presentation and Disclosures The Company expects that the new standard will result in a change to the accounting policies for insurance contracts together with amendments to presentation and disclosures. Impact: The Company is currently assessing the impact of the application and implementation of IFRS 17. As of the date of the publication of these financial statements, the financial impact of adopting the standard has yet to be fully assessed by the Company. The Company expects a material impact on measurement and disclosure of insurance and cession that will affect both the statement of income and the statement of financial position. The Company has decided not to early adopt this new standard. IFRS 17 - “Insurance Contracts”-(Continued) Impact:-(Continued) The Company has started its implementation process and has set up a project team, supervised by an IFRS executive management committee. Impact area
(A SAUDI JOINT STOCK COMPANY) NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER, 2021 3SIGNIFICANT ACCOUNTING POLICIES-(CONTINUED) ASTANDARDS, INTERPRETATIONS, AND AMENDMENTS TO EXISTING STANDARDS-(Continued) IFRS 17 - “Insurance Contracts”-(Continued) Impact:-(Continued) The Company is currently in design phase of IFRS 17 implementation which requires developing and designing new processes and procedures for the business including any system developments required under IFRS 17 and detailed assessment of business requirements. Following are the main areas under design phase and status of the progress is as follows: Major areas of design phase Summary of progress
The Company has started its implementation process and has set up a project team, supervised by Company's CEO. Furthermore, to assess financial and operational impact of IFRS-17, the Company has hired SHMA as their consultants. The effective interpretations/improvement/amendments do not have material impact on these financial statements of the Company. i)Insurance contracts Insurance contracts are defined as those containing insurance risk at the inception of the contract or those where at the inception of the contract there is a scenario with commercial substance of existence of insurance risk. This insurance risk is dependent on both the probability of an insured event and the magnitude of its potential effect. Once a contract has been classified as an insurance contract, it remains an insurance contract for the remainder of its lifetime, even if the insurance risk reduces significantly during this year. Insurance contracts are principally divided into marine, property, motor, engineering and accident and liability and are principally short term insurance contracts. Marine insurance is designed to compensate contract holders for damage and liability arising through loss or damage to marine craft and accidents at sea resulting in the total or partial loss of cargoes. For marine insurance, the main risks are loss or damage to marine craft and accidents resulting in the total or partial loss of cargoes. Property insurance contracts mainly compensate the Company’s customers for damage suffered to their properties or for the value of property lost. Customers who undertake commercial activities on their premises could also receive compensation for the loss of earnings caused by the inability to use the insured properties in their business activities (business interruption cover). For property insurance contracts, the main risks are fire, business interruption and burglary. Motor insurance is designed to compensate contract holders for damages suffered to their vehicles or liability to third parties arising through accidents. Contract holders could also receive compensation for fire or theft of their vehicles. In Saudi Arabia, it is compulsory for all vehicles to have minimum third party cover. The Company also issues comprehensive motor policies. Such motor policies cover damages to vehicles due to storm, tempest, flood, fire, theft and personal accident. Accident insurance includes money insurance, fidelity guarantee insurance, business all risk insurance, business travel insurance and exhibition insurance. Liability insurance includes general third-party liability, product liability, workmen’s compensation/employer’s liability and professional indemnity cover protecting the insured’s legal liability arising out of acts of negligence during their business operations. Engineering insurance covers two principal types (a) “Contractors all risk” insurance offering cover during erection or construction of buildings or civil engineering works such as houses, shops, blocks of flats, factory buildings, roads, buildings, roads, bridges, sewage works and reservoirs. (b) “Erection all risk” insurance offering cover during the erection or installation of plant and machinery such as power stations, oil refineries, chemical works, cement works, metallic structures or any factory with plant and machinery. The Engineering line of business also includes machinery breakdown insurance and electronic equipment insurance. Medical insurance is designed to compensate holders for expenses incurred in treatment of a disease, illness or injury. Medical insurance is primarily offered to corporate customers with a large population to be covered under the policy Claim and loss adjustment expenses are charged to income as incurred based on the estimated liability for compensation owed to contract holders or third parties damaged by the contract holders. They include direct and indirect claims settlement costs and arise from events that have occurred up to the balance sheet date even if they have not yet been reported to the Company. The Company does not discount its liabilities for unpaid claims. Liabilities for unpaid claims are estimated using the input of assessments for individual cases reported to the Company and statistical analyses for the claims incurred but not reported and to estimate the expected ultimate cost of more complex claims that may be affected by external factors such as court decisions. NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER, 2021 3 ii) SIGNIFICANT ACCOUNTING POLICIES-(CONTINUED) Reinsurance contracts held In order to optimise financial exposure from large claims, the Company enters into reinsurance agreements with local and internationally reputable reinsurers. Claims receivable from reinsurers are estimated in a manner consistent with the claim liability and in accordance with the reinsurance contracts. These amounts, if any, are shown as “Reinsurers’ share of outstanding claims” in the statement of financial position until the claim is agreed and paid by the Company. Once the claim is paid, the amount due from the reinsurers in connection with the paid claim is transferred to amounts due from / (to) reinsurers. At each reporting date, the Company assesses whether there is any indication that a reinsurance asset may be impaired. Where an indicator of impairment exists, the Company makes a formal estimate of recoverable amount. Where the carrying amount of a reinsurance asset exceeds its recoverable amount, the asset is considered impaired and is written down to its recoverable amount. iii)
Recognition of premium Premiums and commission are recorded in the statement of income based on straight line method over the insurance policy coverage period except for long term polices (construction and engineering) and marine cargo. Unearned premiums are calculated on a straight line method over the insurance policy coverage except for: Last three months premium at a reporting date is considered as unearned in respect of marine cargo; Pre-defined calculation for Engineering class of business for risks undertaken that extend beyond a single year. In accordance with this calculation, lower premiums are earned in the first year which gradually increases towards the end of the tenure of the policy; and Unearned premiums represent the portion of premiums written relating to the unexpired period of coverage. The change in the provision for unearned premium is taken to the statement of income in the same order that revenue is recognised over the period of risk. Investment income Investment income on debt instruments classified under held to maturity investments and murabaha deposits are accounted for on an effective interest basis. Dividend income Dividend income on equity instruments classified under fair value through statement of income (FVSI) investments is recognized when the right to receive payment is established. iv)
Claims consist of amounts payable to policyholders and third parties and related loss adjustment expenses, net of salvage and other recoveries. Gross outstanding claims comprise the gross estimated cost of claims incurred but not settled at the statement of financial position date together with related claims handling costs, whether reported by the insured or not. Provisions for reported claims not paid as of the statement of financial position date are made on the basis of individual case estimates. In addition, a provision based on management’s judgment and the Company’s prior experience is maintained for the cost of settling claims incurred but not reported including related claims handling costs at the statement of financial position date. The outstanding claims are shown on a gross basis and the related share of the reinsurers is shown separately. Further, the Company does not discount its liability for unpaid claims as substantially all claims are expected to be paid within one year of the statement of financial position date. NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER, 2021 3 SIGNIFICANT ACCOUNTING POLICIES-(CONTINUED) V) Salvage and subrogation reimbursement Some insurance contracts permit the Company to sell (usually damaged) assets acquired in settling a claim (for example, salvage). The Company may also have the right to pursue third parties for payment of some or all costs (for example, subrogation). Estimates of salvage recoveries are included as an allowance in the measurement of the outstanding claims liability. The allowance is the amount that can reasonably be recovered from the disposal of the asset. Subrogation reimbursements are also considered as an allowance in the measurement of the outstanding claims liability. The allowance is the assessment of the amount that can be recovered from the third party. vi) vii) viii) ix) a)
Commissions and other costs directly related to the acquisition and renewal of insurance contracts are deferred and amortized over the terms of the insurance contracts to which they relate, similar to premiums earned. All other acquisition costs are recognized as an expense when incurred. Amortization is recorded in the “Policy acquisition costs” in the statement of income. Changes in the expected useful life or the expected pattern of consumption of future economic benefits embodied in the asset are accounted for by changing the amortization period and are treated as a change in accounting estimate. An impairment review is performed at each reporting date or more frequently when an indication of impairment arises. If the assumptions relating to future profitability of these policies are not realized, the amortization of these costs could be accelerated and this may also require additional impairment write-offs in the statement of income. Deferred policy acquisition costs are also considered in the liability adequacy test at each reporting date. Liability adequacy test At each statement of financial position date, liability adequacy tests are performed to ensure the adequacy of the insurance contracts liabilities net of related deferred policy acquisition costs. In performing these tests management uses current best estimates of future contractual cash flows and claims handling and administration expenses. Any deficiency in the carrying amounts is immediately charged to the statement of income by establishing a provision for losses arising from liability adequacy tests accordingly. Receivables Premiums receivable are stated at gross written premiums receivable from insurance contracts, less an allowance for any uncollectible amounts. Premiums and reinsurance balances receivable are recognised when due and measured on initial recognition at the fair value of the consideration received or receivable. The carrying value of receivable is reviewed for impairment and whenever events or circumstances indicate that the carrying amount may not be recoverable, the impairment loss is recorded in “Other general and administrative expenses” in the statement of income. Receivable balances are derecognised when the Company no longer controls the contractual rights that comprise the receivable balance, which is normally the case when the receivable balance is sold, or all the cash flows attributable to the balance are passed through to an independent third party. Receivables disclosed in note 5 fall under the scope of IFRS 4 “Insurance contracts”. Investments Available-for-sale investments Available-for-sale financial assets are those non-derivative financial assets that are neither classified as held for trading or held to maturity or loans and receivables, nor are designated at fair value through profit or loss. Such investments are initially recorded at cost, being the fair value of the consideration given including transaction costs directly attributable to the acquisition of the investment and subsequently measured at fair value. Cumulative changes in fair value of such investments are recognized in other comprehensive income in the statement of comprehensive income under “Net change in fair value – Available for sale investments”. Realized gains or losses on sale of these investments are reported in the related statements of income under “Realized gain / (loss) on investments available for sale investments.” Dividend, commission income and foreign currency gain/loss on available-for-sale investments are recognized in the related statements of income or statement of comprehensive income - shareholder’s operations, as part of the net investment income / loss. Any significant or prolonged decline in fair value of available-for-sale investments is adjusted for and reported in the related statement of comprehensive income, as impairment charges. Fair values of available-for-sale investments are based on quoted prices for marketable securities or estimated fair values. a)Available-for-sale investments-(Continued) The fair value of commission-bearing items is estimated based on discounted cash flows using commission for items with similar terms and risk characteristics. For unquoted investments, fair value is determined by reference to the market value of a similar investment or where the fair values cannot be derived from active markets, they are determined using a variety of valuation techniques. The input to these models is taken from observable markets where possible, but where this is not feasible, a degree of judgment is required in establishing fair values. Reclassification: The Company evaluates whether the ability and intention to sell its AFS financial assets in the near term is still appropriate. When, in rare circumstances, the Company is unable to trade these financial assets due to inactive markets, the Company may elect to reclassify these financial assets if management has the ability and intention to hold the assets for the foreseeable future or until maturity. Reclassification to loans and receivables is permitted when the financial asset meets the definition of loans and receivables and management has the intention and ability to hold these assets for the foreseeable future or until maturity. The reclassification to HTM is permitted only when the entity has the ability and intention to hold the financial asset until maturity. For a financial asset reclassified out of the available-for-sale category, the fair value at the date of reclassification becomes its new amortized cost and any previous gain or loss on that asset that has been recognised in equity is amortized to profit or loss over the remaining life of the investment using the EIR. Any difference between the new amortized cost and the maturity amount is also amortized over the remaining life of the asset using the Effective Interest Rate “EIR”. If the asset is subsequently determined to be impaired, then the amount recorded in equity is reclassified to the statement of income. b) Held for trading Investments in this category are classified if they are held for trading or designated by management as FVSI on initial recognition. Investments classified as trading are acquired principally for the purpose of selling or repurchasing in short term and are recorded in the statement of financial position at fair value. Changes in fair value are recognized in net trading income/loss. An investment may be designated at FVSI by the management, at initial recognition, if it satisfies the criteria laid down by IAS 39 except for the equity instruments that do not have a quoted price in an active market and whose fair values cannot be reliably measured. Investments at FVSI are recorded in the statement of financial position at fair value. Changes in the fair value are recognised in the statement of income for the year in which it arises. Transaction costs, if any, are not added to the fair value measurement at initial recognition of FVSI investments. Special commission income and dividend income on financial assets held as FVSI are reflected as either trading income or income from FVSI financial instruments in the statement of income. Reclassification: Investments at FVSI are not reclassified subsequent to their initial recognition, except that non-derivative FVSI instrument, other than those designated as FVSI upon initial recognition, may be reclassified out of the FVSI fair value through the statement of income (i.e., trading) category if they are no longer held for the purpose of being sold or repurchased in the near term, and the following conditions are met: If the financial asset would have met the definition of loans and receivables, if the financial asset had not been required to be classified as held for trading at initial recognition, then it may be reclassified if the entity has the intention and ability to hold the financial asset for the foreseeable future or until maturity. If the financial asset would not have met the definition of loans and receivables, and then it may be reclassified out of the trading category only in ‘rare circumstances’. NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER, 2021 3 ix) c) SIGNIFICANT ACCOUNTING POLICIES-(CONTINUED) Investments-(Continued) Held to maturity Investments having fixed or determinable payments and fixed maturity that the Company has the positive intention and ability to hold to maturity are classified as held to maturity. Held to maturity investments are initially recognised at fair value including direct and incremental transaction costs and subsequently measured at amortised cost, less provision for impairment in value. Amortised cost is calculated by taking into account any discount or premium on acquisition using an effective yield basis. Any gain or loss on such investments is recognised in the statement of income when the investment is derecognised or impaired. Reclassification: Investments classified as held to maturity cannot ordinarily be sold or reclassified without impacting the Comapny’s ability to use this classification and cannot be designated as a hedged item with respect to commission rate or prepayment risk, reflecting the longer-term nature of these investments. However, sales and reclassifications in any of the following circumstances would not impact the Comapny’s ability to use this classification Sales or reclassifications that are so close to maturity that the changes in market rate of commission would not have a significant effect on the fair value. Sales or reclassifications after the Company has collected substantially all the assets’ original principal Sales or reclassifications attributable to non-recurring isolated events beyond the Comapny’s control that could not have been reasonably anticipated. x) xi) xii)
The derecognition of a financial instrument takes place when the Company no longer controls the contractual rights that comprise the financial instrument, which is normally the case when the instrument is sold, or all the cash flows attributable to the instrument are passed through to an independent third party and the Company has also transferred substantially all risks and rewards of ownership. Offsetting Financial assets and financial liabilities are offset and the net amount reported in the statement of financial position only when there is a currently enforceable legal right to offset the recognised amounts and there is an intention to settle on a net basis, or to realize the assets and settle the liability simultaneously. Income and expense is not offset in the statement of other comprehensive income unless required or permitted by any accounting standard or interpretation. Trade date accounting All regular way purchases and sales of financial assets are recognized / derecognized on the trade date (i.e. the date that the Company commits to purchase or sell the assets). Regular way purchases or sales are purchases or sales of financial assets that require settlement of assets within the time frame generally established by regulation or convention in the market place. xiii) Impairment of financial assets The Company assesses, at each reporting date, whether there is objective evidence that a financial asset or a group of financial assets is impaired. An impairment exists if one or more events that has occurred since the initial recognition of the asset (an incurred ‘loss event’), has an impact on the estimated future cash flows of the financial asset or the group of financial assets that can be reliably estimated. Evidence of impairment may include: Significant financial difficulty of the issuer or debtor; A breach of contract, such as a default or delinquency in payments; It becoming probable that the issuer or debtor will enter bankruptcy or other financial reorganization; The disappearance of an active market for that financial asset because of financial difficulties; or Observable data indicating that there is a measurable decrease in the estimated future cash flow from a group of financial assets since the initial recognition of those assets, although the decrease cannot yet be identified with the individual financial assets in the Company, including: Adverse changes in the payment status of issuers or debtors in the Company; or National or local economic conditions at the country of the issuers that correlate with defaults on the assets. If there is objective evidence that an impairment loss on a financial asset exists, the impairment is determined as follows: For assets carried at fair value, impairment is the significant or prolong decline in the fair value of the financial asset. For assets carried at amortized cost, impairment is based on estimated future cash flows that are discounted at the original effective commission rate. For available-for-sale financial assets, the Company assesses at each reporting date whether there is objective evidence that an investment or a group of investments is impaired. In the case of debt instruments classified as available for sale, the Company assesses individually whether there is an objective evidence of impairment. Objective evidence may include indications that the borrower is experiencing significant financial difficulty, default or delinquency in special commission income or principal payments, the probability that it will enter bankruptcy or other financial reorganization and where observable data indicates that there is a measurable decrease in the estimated future cash flows, such as changes in economic conditions that correlate with defaults. However, the amount recorded for impairment is the cumulative loss measured as the difference between the amortized cost and the current fair value, less any impairment loss on that investment previously recognized in the statement of income and statement of other comprehensive income. If, in a subsequent period, the fair value of a debt instrument increases and the increase can be objectively related to credit event occurring after the impairment loss was recognized in the statement of income and statement of other comprehensive income, the impairment loss is reversed through the statement of income and statement other of comprehensive income. In the case of debt instruments classified as available for sale, the Company assesses individually whether there is an objective evidence of impairment. Objective evidence may include indications that the borrower is experiencing significant financial difficulty, default or delinquency in special commission income or principal payments, the probability that it will enter bankruptcy or other financial reorganization and where observable data indicates that there is a measurable decrease in the estimated future cash flows, such as changes in economic conditions that correlate with defaults. However, the amount recorded for impairment is the cumulative loss measured as the difference between the amortized cost and the current fair value, less any impairment loss on that investment previously recognized in the statement of income and statement of other comprehensive income. If, in a subsequent period, the fair value of a debt instrument increases and the increase can be objectively related to credit event occurring after the impairment loss was recognized in the statement of income and statement of other comprehensive income, the impairment loss is reversed through the statement of income and statement of other comprehensive income. For equity investments held as available-for-sale, a significant or prolonged decline in fair value below its cost represents objective evidence of impairment. The impairment loss cannot be reversed through statement of income as long as the asset continues to be recognised i.e. any increase in fair value after impairment has been recorded can only be recognised in other comprehensive income. On derecognition, any cumulative gain or loss previously recognised in other comprehensive income is included in the statement of income under “Realized gain / (loss) on investments available for sale investments”. NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER, 2021 3 SIGNIFICANT ACCOUNTING POLICIES-(CONTINUED) xiii) Impairment of financial assets-(Continued) The determination of what is ‘significant’ or ‘prolonged’ requires judgement. A period of 12 months or longer is considered to be prolonged and a decline of 30% from original cost is considered significant as per Company policy. In making this judgement, the Company evaluates, among other factors, the duration or extent to which the fair value of an investment is less than its cost. In making an assessment of whether an investment in debt instrument is impaired, the Company considers the factors such as market’s assessment of creditworthiness as reflected in the bond yields, rating agencies’ assessment of creditworthiness, country’s ability to access the capital markets for new debt issuance and probability of debt being restructured, resulting in holders suffering losses through voluntary or mandatory debt forgiveness. The amount recorded for impairment is the cumulative loss measured as the difference between the amortised cost and the current fair value, less any impairment loss on that investment previously recognised in the statement of income and statement of other comprehensive income. xiv) Intangible assets Computer software are shown at historical cost. They have a finite useful life and are subsequent carried at cost less accumulated amortization and impairment losses. The Company amortizes computer software with a limited useful life using straight-line method over the following periods:
xv)
Property and equipment are stated at cost less accumulated depreciation and any impairment losses. Subsequent costs are included in the asset’s carrying amount or recognised as a separate asset, as appropriate, only when it is probable that future economic benefits associated with the item will flow to the Company and the cost of the item can be measured reliably. All other repairs and maintenance are charged to the statement of income during the financial period in which they are incurred. Land is not depreciated. The cost of other items of property and equipment is depreciated on the straight line method to allocate the cost over estimated useful lives, as follows:
Gains and losses on disposals are determined by comparing proceeds with carrying amount and are included in the statement of insurance operations and accumulated surplus. Maintenance and normal repairs which do not materially extend the estimated useful life of an asset are charged to the statement of shareholders’ operations as and when incurred. Major renewals and improvements, if any, are capitalized and the assets so replaced are retired. The assets’ residual values and useful lives are reviewed at each reporting date and adjusted if appropriate. The carrying values of these assets are reviewed for impairment when event or changes in circumstances indicate that the carrying value may not be recoverable. If any such indication exists and where the carrying values exceed the estimated recoverable amount, the assets are written down to their recoverable amount. xvi) Leases Definition of lease Under IFRS 16, a contract is, or contains, a lease if the contract conveys a right to control the use of an identified asset for a period of time in exchange of consideration. The Company assess whether a contract is or contains a lease based on the new definition of a lease. On transition to IFRS 16, the Company elected to apply the practical expedients to grandfather the assessment of which transactions are leases. As a lessee The Company leases its offices, and as a lessee, the Company previously classified leases as operating leases based on its assessment of whether the lease transferred substantially all the risks and rewards of ownership. Under IFRS 16, the Company recognizes right-of-use assets and lease liabilities for most leases - i.e. these leases are on balance sheet. The Company recognizes a right-of-use asset and a lease liability at the lease commencement date. The right-of-use is initially measured at cost, and subsequently at cost less any accumulated depreciation and impairment losses and adjusted with certain remeasurements of lease liability. The cost of right-of-use assets includes the initial measurement of the lease liability adjusted for any lease payments made at or before the commencement date, any initial direct costs incurred and an estimate of costs to dismantle, less any lease incentive received. The estimated useful life of right-of-use assets are determined considering the term of the lease. The lease liability is initially measured at present value of the lease payments that are not paid at the commencement date, discounted using the Company’s incremental borrowing rate (if the interest rate implicit in the lease is not available).The lease liability is subsequently increased by the interest cost on the lease liability and decreased by the lease payment made. It is remeasured when there is a change in the future lease payments arising from the change in an index or rate, a change in the estimate of the amount expected to be payable under residual value guarantee, or as appropriate, changes in the assessment of whether a purchase or extension option is reasonably certain to be exercised or termination option is reasonably certain not to be exercised. The lessee will generally recognize the amount of the re-measurement of the lease liability as an adjustment to the right-of-use asset Lessor accounting under IFRS 16 is substantially unchanged from today’s accounting under IAS 17. Lessors will continue to classify all leases using the same classification principle as in IAS 17 and distinguish between two types of leases: operating and finance leases. xvii) Impairment of non-financial assets Assets that have an indefinite useful life – for example, land – are not subject to depreciation and are tested annually for impairment. Assets that are subject to depreciation are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. An impairment loss is recognized for the amount by which the asset’s carrying amount exceeds its recoverable amount. The recoverable amount is the higher of an asset’s fair value less costs to sell and value in use. For the purpose of assessing impairment, assets are grouped at the lowest level for which there are separately identifiable cash flows (cash-generating units). xviii) Employees’ terminal benefits The Company operates an end of service benefit plan for its employees based on the prevailing Saudi Labor Laws. Accruals are made at the present value of expected future payments in respect of services provided by the employees up to the end of the reporting period using the projected unit credit method. Consideration is given to expected future wage and salary levels, experience of employee departures and periods of service. Expected future payments are discounted using market yields at the end of the reporting period of high-quality corporate bonds with terms and currencies that match, as closely as possible, the estimated future cash outflows. The benefit payments obligation is discharged as and when it falls due. Re- measurements (actuarial gains/ losses) as a result of experience adjustments and changes in actuarial assumptions are recognised in statement of other comprehensive income. NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER, 2021 3 xix) xx) xxi) xxii) SIGNIFICANT ACCOUNTING POLICIES-(CONTINUED) Zakat and income tax The Company is subject to zakat in accordance with the regulations of the Zakat, Tax and Customs Authority (ZATCA). Zakat is computed on the Saudi shareholders’ share of equity or net income using the basis defined under the Zakat regulations. Income taxes are computed on the foreign shareholders' share of net adjusted income for the year. Zakat and income tax is accrued on a quarterly basis. Additional amounts payable, if any, at the finalization of final assessments are accounted for when such amounts are determined Zakat expense is charged to the profit or loss. Zakat is not accounted for as income tax and as such no deferred tax is calculated relating to zakat. The Company withholds taxes on certain transactions with non-resident parties in the Kingdom of Saudi Arabia as required under Saudi Arabian Income Tax Law. Dividend distribution Dividend distribution to the Company’s shareholders is recognised as a liability in the Company’s financial statements in the period in which the dividends are approved by the Company’s shareholders. Cash and cash equivalents Cash and cash equivalents comprise cash in hand and balances with banks including murabaha deposits with less than three months’ maturity from the date of acquisition. Cash flow statement The Company’s main cash flows are from insurance operations which are classified as cash flow from operating activities. Cash flows generated from investing and financing activities are classified accordingly. xxiii) Provision Provisions are recognised when the Company has an obligation (legal or constructive) as a result of a past event, and it is probable that an outflow of resources embodying economic benefits will be required to settle the obligation and a reliable estimate can be made of the amount of the obligation. xxiv) Foreign currencies Transactions in foreign currencies are recorded in Saudi Arabian Riyals at the exchange rate prevailing at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies are retranslated to Saudi Riyals at the rate of exchange prevailing at the statement of financial position date. All differences are taken to the statements of income and other comprehensive income. Non-monetary items that are measured in terms of historical cost in a foreign currency are translated using the exchange rate as at the date of the initial transaction and are not subsequently restated. Foreign exchange gains or losses on available-for-sale investments are recognized in “Other income, net” in the statement of income and statement of other comprehensive income. As the Company’s foreign currency transactions are primarily in US dollars, foreign exchange gains and losses are not significant. xxv)
The fair value of financial assets are based on quoted prices for marketable securities or estimated fair values. The fair value of commission-bearing items is estimated based on discounted cash flow using commission for items with similar terms and risk characteristics. For financial assets where there is no active market, fair value is determined by reference to the market value of a similar financial assets or where the fair values cannot be derived from active market, they are determined using a variety of valuation techniques. The inputs of this models is taken from observable market where possible, but where this is not feasible, a degree of judgment is required in establishing fair values. 3 xxvi) xxvii) xxviii) xxix) xxix) SIGNIFICANT ACCOUNTING POLICIES-(CONTINUED) Operating segments A segment is a distinguishable component of the Company that is engaged in providing products or services (a business segment), which is subject to risk and rewards that are different from those of other segments. For management purposes, the Company is organized into business units based on their products and services and has the following reportable segments: Medical provides compensation to policy holders for expenses incurred in treatment of a disease, illness or injury. Motor provides coverage against losses and liability related to motor vehicles. Energy and engineering insurance Other includes property, marine, aviation, accident and liability categories. Operating segments are reported in a manner consistent with the internal reporting provided to the chief operating decision- maker. The chief operating decision-maker, who is responsible for allocating resources and assessing performance of the operating segments, has been identified as the chief executive officer that makes strategic decisions. No inter-segment transactions occurred during the year. O Statutory reserves In accordance with the Company’s by-laws, the Company shall allocate 20% of its net income from shareholders operations each year to the statutory reserve until it has built up a reserve equal to the share capital. The reserve is not available for distribution. Accounts and other payables Liabilities are recognised for amounts to be paid in the future for goods or services received, whether billed by the Supplier or not. Provision for outstanding claims Judgement by management is required in the estimation of amounts due to policyholders and third parties arising from claims made under insurance contracts. Such estimates are necessarily based on assumptions about several factors involving varying degrees of judgement and uncertainty and actual results may differ from management’s estimates resulting in future changes in estimated liabilities. The Company estimates its claims based on its experience of its insurance portfolio. Claims requiring court or arbitration decisions, if any, are estimated individually. Management reviews its provisions for claims incurred, and claims incurred but not reported, on a monthly basis. Any difference between the provisions at the statement of financial position date and settlements and provisions in the following year is included in the statement of insurance operations and accumulated surplus for that year. The provision for outstanding claims, as at 31 December, is also verified and certified by an independent actuary. Surplus from insurance operations Ten-percent (10%) of the net surplus from insurance operations shall be distributed to the policyholders directly, or in the form of reduction in premiums for the next year. The remaining ninety-percent (90%) of the net surplus shall be transferred to the shareholders | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Disclosure of notes forming part of accounts [abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Disclosure of property and equipment [text block] | 12 PROPERTY AND EQUIPMENT, NETSAR’000MotorVehicles Furniture, fittings andoffice equipment ComputerEquipment Leasehold improvements Total2021 Total2020 Cost: As at 01 January 116 7,416 7,065 8,226 22,823 19,381Additions during the year - 185 454 1,241 1,880 3,442As at 31 December 116 7,601 7,519 9,467 24,703 22,823Accumulated depreciation: As at 01 January 115 6,682 4,779 5,933 17,509 15,783Charge for the year - 489 705 589 1,783 1,726As at 31 December 115 7,171 5,484 6,522 19,292 17,509Net book value As at 31 December, 2021 1 430 2,035 2,945 5,411 -As at 31 December, 2020 1 734 2,286 2,293 5,314 5,314 NOTES TO THE FINANCIAL STATEMENTSFOR THE YEAR ENDED 31 DECEMBER, 2021 13 INTANGIBLE ASSETS 31 December, 31 December, 2021 2020 SAR’000Cost:As at 01 January 10,181 9,449Additions during the year 1,873 732As at 31 December 12,054 10,181Accumulated amortisation:As at 01 January 5,430 4,441Charge for the year 1,039 989As at 31 December 6,469 5,430Net book Value 5,585 4,751 | 11 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Disclosure of leases [text block] | 9 RIGHT OF USE ASSETS, NETSAR’000 31 December, 31 December, 2021 2020 Cost:At beginning of the year 10,073 9,985Additions during the year 18 88As at end of year 10,091 10,073Accumulated amortizationAt beginning of the year (4,851) (2,758) Charge for the year (2,011) (2,093) As at end of year (6,862) (4,851)Net book value | 9 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Disclosure of investments in available-for-sale investments [text block] | AVAILABLE-FOR-SALE INVESTMENTSAll available-for-sale investments are in shareholders’ operations and comprise the following :SAR’000 31 December, December 31, 2021 2020 Investment in Sukuk 20,000 20,000 Quoted securities 11,508 11,177 Unquoted securities 1,923 1,923 Quoted local real estate fund 17,290 16,159 50,721 49,259b) Movements in available-for-sale investments are as follows: SAR’000 Investment in Sukuk Quoted securities Unquoted securities Units in quoted local real estate fund Total As at January 01, 2021 20,000 11,177 1,923 16,159 49,259Disposals during the year - - - - -Changes in fair value of investments - 331 - 1,131 1,462As at 31 December 2021 20,000 11,508 1,923 17,290 50,721SAR’000 Investment in Sukuk Quoted securities Unquoted securities Units in quoted local real estate fund Total As at January 01, 2020 25,000 11,256 1,923 12,927 51,106Disposals during the year (5,000) - - - (5,000)Changes in fair value of investments - (79) - 3,232 3,153As at 31 December 2020 20,000 11,177 1,923 16,159 49,259 | 7 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Disclosure of premiums/ contributions and insurance/ reinsurance or takaful/ retakaful balance receivables [text block] | 6 PREMIUM AND REINSURERS' RECEIVABLE, NETReceivables comprise amounts due from the following:SAR’000 31 December,2021 31 December,2020 Due from policyholders 56,009 78,842Due from policyholders – related parties – (Note 21) 1,820 1,881Due from brokers and agents 44,646 21,309Receivables from reinsurers 6,447 5,329 108,922 107,361Less: Allowance for doubtful debts (Note 6.1) (10,507) (8,723) Premium and reinsurers’ receivable – net 98,415 98,638 6.1 As at 31 December, 2021, the movement in allowance for doubtful debts during the year was as follows :SAR’000 31 December,2021 31 December,2020 Balance at the beginning of the yearProvided / (reversed) during the yearBalance at the end of the year 8,723 13,0771,784 (4,354) 10,507 8,723 As at 31 December, the ageing of receivables is as follows: Neither past Past due but not impaired Past due but impaired Total due nor impaired Less than30 days 31-90 days 91-180 daysSAR’000 181-360 days More than 360 days Premium and reinsurers’ receivable – net Due from policyholders 85,215 6,176 62,692 1,348 4,133 4,944 5,922Due from policyholders – related parties – (Note 21) 1,820 - - - 51 7 1,762Due from brokers and agents 15,441 - 5,835 3,704 1,810 1,032 3,060Receivables from reinsurers 6,446 - - 6,446 - - -Less: Allowance for doubtful debts (Note 6.1) (10,507) - - - (900) (1,495) (8,112)2021 98,415 6,176 68,527 11,498 5,094 4,488 2,632 Neither past Past due but not impaired Past due but impaired Total due nor impaired Less than30 days 31-90 days 91-180 daysSAR’000 181-360 days More than 360 days Premium and reinsurers’ receivable – net 4,552 4,660 5,1875 5 1,871Due from policyholders 78,842 - 11,533 52,910 Due from policyholders – related parties – (Note 21) 1,881 - - - Due from brokers and agents 21,309 - 1,804 15,412 1,173 1,572 1,348Receivables from reinsurers 5,329 - 1,805 - - 1,154 2,370Less: Allowance for doubtful debts (Note 6.1) (8,723) - - - (858) (1,560) (6,305)2020 98,638 - 15,142 68,322 4,872 5,831 4,47133 ALLIED COOPERATIVE INSURANCE GROUP (ACIG) (A SAUDI JOINT STOCK COMPANY)NOTES TO THE FINANCIAL STATEMENTSFOR THE YEAR ENDED 31 DECEMBER, 20216 PREMIUM AND REINSURERS' RECEIVABLE, NET-(CONTINUED)The Company only enters into insurance and reinsurance contracts with recognized, creditworthy third parties. It is the Company’spolicy that all customers who wish to trade on credit terms are subject to credit verification procedures. In addition, receivables aremonitored on an ongoing basis in order to reduce the Company’s exposure to bad debts.The five largest customers accounts for 44.4 % (31 December 2020: 7 %) of the premiums receivable as at 31 December 2021. | 6 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Disclosure of cash and cash equivalents [text block] | 4 CASH AND CASH EQUIVALENTSCash and cash equivalents included in the statement of cash flows comprise the following:SAR’000 31 December, 31 December, Insurance operationsBank balances and cashDeposits maturing within 3 month from the acquisition dateShareholders’ operationsBank balances and cashDeposits maturing within 3 month from the acquisition date 2021 2020 49,928 50,5204.1 3,045 19,16652,973 69,686- 14,2014.1 - 61,050- 75,25152,973 144,937 4.1 These deposits earn commission at an average rate of 1.2% per annum as at 31 December, 2021 ( 31 December 2020:1.08%). 5 TERM DEPOSITS SAR’000 31 December,2021 31 December,2020 Insurance operationsTerm depositsShareholders’ operationsTerm deposits 5.1 182,367 119,331182,367 119,3315.1 - -- -182,367 119,331 5.1 Term deposits are held with the commercial banks. These term deposits are denominated in Saudi Arabian Riyals and have been an original maturity of more than three months and less than twelve months. The carrying amounts of these term deposits reasonably approximate their fair values at the reporting date. These deposit earn commission at an average of1.07% per annum as at 31 December 2021 (31 December 2020: 2.67%) | 4 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Disclosure of statutory deposit [text block] | STATUTORY DEPOSIT SAR’000 31 December, 31 December, 2021 2020 Shareholders’ operationsStatutory deposit 30,000 30,000As required by Saudi Arabian Insurance Regulations, the Company had deposited 15% of its initial pre-reduction paid up capital of SAR 200 million (Note 23), in a bank designated by the Saudi Central Bank (SAMA). The Company cannot withdraw this deposit without SAMA’s approval and commission accruing on this deposit is payable to SAMA. | 10 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Disclosure of employees' end of service benefits [text block] | 17 EMPLOYEES’ TERMINAL BENEFITSThe Company operates an end of service benefit plan for its employees based on the prevailing Saudi Labor Laws. Accruals are made in accordance with the actuarial valuation under projected unit credit method while the benefit payments obligation is discharged as and when it falls due. The amounts recognized in the statement of financial position and movement in the obligation during the year based on its present value are as follows: 17.1 The amounts recognized in the statement of financial position and movement in the obligation during the year based on its present value are as follows: 31 December, 31 December, 2021 2020 SAR’000Present value of defined benefit obligation 12,968 14,006 17.2 Movement of defined benefit obligation 31 December, 31 December, 2021 2020 SAR’000 Opening balance 14,006 12,011 Charge to statement of income 2,184 2,243 Charge to statement of other comprehensive income 473 233 Payment of benefits during the year (3,695) (481) Closing balance 12,968 14,00617.3 Reconciliation of present value of defined benefit obligation 31 December, 31 December, 2021 2020 SAR’000Present value of defined benefit obligation as at 1 January 14,006 12,011Current service costs 1,892 1,869Financial costs 292 374Actuarial loss/ (gain) from experience adjustments 473 233Benefits paid during the year (3,695) (481)Present value of defined benefit obligation as at 31 December 12,968 14,00617.4 Principal actuarial assumptions 31 December, 31 December, 2021 2020 SAR’000Valuation discount rate 2.75% 2.40%Expected rate of increase in salary level across different age bands 1.00% 1.00% ALLIED COOPERATIVE INSURANCE GROUP (ACIG) (A SAUDI JOINT STOCK COMPANY)NOTES TO THE FINANCIAL STATEMENTSFOR THE YEAR ENDED 31 DECEMBER, 202117 EMPLOYEES’ TERMINAL BENEFITS-(CONTINUED) 17.4 Principal actuarial assumptions-(Continued) The impact of changes in sensitivities on present value of defined benefit obligation is as follows: 31 December, 31 December, 2021 2020 SAR’000Valuation discount rate -Increase by 1% 11,934 12,545-Decrease by 1% 14,185 15,744Expected rate of increase in salary level across different age bands -Increase by 1% 14,259 15,890-Decrease by 1% 11,853 12,451Mortality rate -1 year Mortality age set back 12,971 14,013-1 year Mortality age set forward 12,964 14,000Withdrawal turnover -Increase by 10% 12,964 14,018-Decrease by 10% 12,920 13,992 | 16 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Disclosure of gross unearned premiums/ contributions [text block] | 8 TECHNICAL RESERVES (INSURANCE OPERATIONS) 8.1 Net outstanding claims and reservesNet outstanding claims and reserves comprise of the following: SAR’000 31 December, 31 December, 2021 2020 Outstanding claims 34,605 26,094 Claims incurred but not reported 80,865 68,643 Premium deficiency reserve 35,727 9,516 Other technical reserves 1,798 2,482 152,995 106,735 Less: Reinsurers’ share of outstanding claims (12,955) (11,908) Reinsurers’ share of claims incurred but not reported (8,498) (8,020) (21,453) (19,928) Net outstanding claims and reserves 131,542 86,8078.2 Movement in unearned premiums Movement in unearned premiums comprise of the following: SAR’000 For the yGross ear ended 31 DecemReinsurance ber, 2021Net Balance as at the beginning of the year 264,469 (27,393) 237,076 Premium written during the year 592,588 (78,531) 514,057 Premium earned during the year (555,313) 71,221 (484,092) Balance as at the end of the year 301,744 (34,703) 267,041SAR’000For the year ended 31 December, 2020Gross Reinsurance NetBalance as at the beginning of the year 254,360 (21,323) 233,037Premium written during the year 515,117 (65,657) 449,460Premium earned during the year (505,008) 59,587 (445,421)Balance as at the end of the year 264,469 (27,393) 237,076 NOTES TO THE FINANCIAL STATEMENTSFOR THE YEAR ENDED 31 DECEMBER, 20218 TECHNICAL RESERVES (INSURANCE OPERATIONS) (CONTINUED)8.3 Deferred policy acquisition costsMovement in deferred policy acquisition costs comprise of the following:SAR’000For the year ended 31 December,2021Gross NetOpening balance 31,659 31,659Incurred during the year 75,100 75,100Amortized during the year (62,706) (62,706) Closing balance 44,053 44,053 SAR’000For the year ended 31 December, 2020Gross NetOpening balance 14,157 14,157Incurred during the year 30,632 30,632Amortized during the year (13,130) (13,130)Closing balance 31,659 31,659 | 8 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Disclosure of accrued expenses and other liabilities [text block] | 15 ACCRUED AND OTHER PAYABLES 31 December, 31 December, 2021 2020 SAR’000Brokers payable 6,995 6,883Accrued expenses 4,358 3,697Third party administrative payable 1,067 2,625Witholding tax payable 2,517 4,822Others 4,018 6,13618,955 24,163 16 SURPLUS DISTRIBUTION PAYABLE 31 December, 31 December, 2021 2020 SAR’000Opening surplus distribution payable as at 1 January 6,409 5,982Total income attributed to the insurance operations during the year - 456Surplus paid during the year (418) (29) Closing surplus distribution payable as at 31 December | 15 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Disclosure of zakat [text block] | ZAKAT AND INCOME TAXThe current year’s zakat provision is based on the following: SAR’000 31 December, 31 December, 2021 2020 Equity 141,000 141,000Opening provisions and other adjustments 36,136 26,498Net book value of long term assets (24,870) (5,314) Accumulated losses (1,431) 7,016Statutory deposit (30,000) (30,000) Unrealized loss on available for sale investments - (49,259)120,835 89,941Adjusted income for the year (85,276) 6,899Zakat base at 2.5% 983 2,319SAR’000 31 December, 31 December, 2021 2020 Balance at the beginning of the year 10,975 8,453Provided during the year 10,576 4,463Payments during the year (2,318) (1,941) Balance at the end of the year 19,233 10,975The differences between the financial and the zakatable results are mainly due to certain adjustments in accordance with the relevant fiscal regulations.Zakat base has been computed based on the Company’s understanding of the Zakat regulations enforced in the Kingdom of Saudi Arabia. The Zakat regulations in Saudi Arabia are subject to different interpretations, and the assessments to be raised by the ZATCA could be different from the declarations filed by the Company.Income tax:SAR’000 31 December,2021 31 December,2020 Balance at the beginning of the year 25 25Balance at the end of the year 25 25Total zakat and income tax 19,258 11,000Status of assessmentsZakat and income tax returns have been filed with the Zakat, Tax and Custom Authority (the “ZATCA ”) for the years ended up to 31 December 2020. Final certificate has been received from the ZATCA for the year ended 31 December 2020. However, the ZATCA has raised an additional assessment in respect of the returns filed for the years ended 31 December 2008, 2009 and 2010 amounting to total SAR 1.86 million which has been paid. The major difference of additional assessment relates to disallowance of a portion of pre-incorporation expenses and withholding tax. The Company has filed an objection against this additional assessment with the Preliminary Tax Objection Committee subsequent to the year end, an adverse decision was received from the Preliminary Tax Objection Committee, upon which the Company filed appeal with the Higher Objection Committee. The Higher Objection Committee issued its decision in favour of the Company with respect to Zakat and rejected the appeal related to withholding tax. The Company has referred the matter to the Board of Grievance for the case of the withholding tax and raised a letter of guarantee in the amount of 1.83 million and also paid the amount of tax SAR 1.27 million. (A SAUDI JOINT STOCK COMPANY) NOTES TO THE FINANCIAL STATEMENTSFOR THE YEAR ENDED 31 DECEMBER, 202122 ZAKAT AND INCOME TAX-(CONTINUED) Status of assessments-(Continued)The Company has raised an objection for an unfavourable assessment raised by the ZATCA for the years ended 31 December 2013 till 2015 with the amount of SAR 4.98 million. The objection is currently under study by the ZATCA. The Company received a claim from the ZATCA for an amount of SAR 5.18 million representing withholding tax, the Company raised an objection against the claim with the General Secretariat of Tax Committee (GSTC) which has been also rejected and now is under appeal with the Appeal Committee for Tax Violation and Disputes.During 2020, the ZATCA issued an assessment for the years 2016 to 2018 claiming additional liability of SAR 7.83 million. The Company has raised an objection against such assessments which has been rejected by the ZATCA. The Company raised the objection to the GSTC and it is currently under study by the committee.During 2021, the ZATCA issued an assessment for the years 2019 to 2020 claiming additional liability of SAR 3.73 million. As at 31 December,2021, the Company is still in the process of decising whether an objection against such assessments needs to be made or not.Income tax:Islamic Development Bank (IDB) being a foreign shareholder, is exempted from income tax. | 22 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Disclosure of deferred tax [text block] | VALUE ADDED TAX (VAT)On September 28, 2020, the Company received from ZATCA VAT assessments for the years ended December 31, 2018 and 2019 claiming additional liability of SAR 1.78 million and SAR 1.98 million for VAT resepctively and SAR 2.85 million and SAR 1.78 million for related penalties respectively. Management has filled an objection against the said assessments and is confident of receiving a favourable outcome. However, as required by the ZATCA regulation, the Company has paid the amount of the tax and was relieved from the penalties in accordance with ZATCA initiative to support the private sector. | 24 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Disclosure of classes of share capital [text block] | 23 SHARE CAPITALAs at 31 December, 2021 and 31 December, 2020, the authorized, subscribed and paid up share capital of the Company was SAR 141 million, divided into 14.1 million shares of SAR 10 each.On January 16, 2020, the Company’s Board of Directors had recommended to reduce the Company’s share capital from SR 200 million to SR 141 million – represented by 5.9 million share - by off-setting with accumulated losses. In an extra-ordinary general meeting held on Muharram 21, 1441H corresponding to August 26, 2020, the shareholders of the Company approved the above recommendation and required changes in the Company by-law relating to the reduction. Accordingly, the share capital and accumulated losses have been reduced to SAR 141 million.The capital reduction is through the reduction of 1 share for every 3.3898 shares held by the shareholders. The purpose of capital reduction is to restructure the capital position of the Company in order to comply with the Companies Law. There is no impact of reduction in capital on the Company’s financial obligations.On Jamad Al-Awwal 21, 1441H corresponding to January 16, 2020, the Board of Directors had recommended an increased in the Company’s capital through right issue with a total value of SR 150 million. On Safar 14, 1442H corresponding to October 1, 2020, the Company obtained approval from SAMA. On Safar 27, 1443H , corresponding to September 20, 2021 the Capital Market authority (CMA) approved the said capital increase. The extra ordinary general meeting of shareholders was held on December, 29 2021 (corresponding to Jumada Al-Awwal, 26, 1443H), to approve the aforementioned capital increase and procedures for the issuance of right shares.Subsequent to year end, following the Shareholders’ approval, on January 01, 2022, the Company announced trading of 15 million right shares starting from 03 January 2022 (corresponding to Jumada Al-Awwal, 30, 1443H) to 10 January 2022 (corresponding to Jumada ath- Thaniyah 07, 1443) The closing date for the subscription of new shares was set at January, 13, 2022 (corresponding to Jumada ath- Thaniyah 09, 1443)Out of 15 Million right shares, 13.3 million shares consisting approximately 89 % of total right shares offer, were subscribed by the existing shareholders. Unsubscribed fraction of shares constituting 16.7 million were sold in market at average share price of SAR 19.02 per share. As of now, the Company is still in the process of fulfilling the remaining regulatory requirements of the aforementioned capital increase. The Company received the proceeds from rights issue on March 7, 2022 and the new share capital amount will be reported in the interim condensed finacial statements for the three months period ended 31 March 2022. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Disclosure of general and administrative expense [text block] | GENERAL AND ADMINISTRATIVE EXPENSES 31 December, 31 December, 2021 2020 SAR’000Employee costs 50,769 47,732Marketing 10,291 9,978Depreciation and amortization 12 & 13 4,833 4,379Legal and professional fees 1,034 2,429Office expenses 3,711 2,215Directors remuneration 1,800 1,863Traveling 676 481Audit expense 595 584Share transfer – Tadawul expense 267 259General assembly expense 20 32Other 8,473 6,639 82,469 76,591 | 26 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Disclosure of earnings per share [text block] | 24 LOSS PER SHARELoss per share for the year has been calculated by dividing the net income for the year by the weighted average number of issued and outstanding shares for the period. The Company have reduced its share capital by offsetting with accumulated loss (note 23), as result the weighted average number of ordinary shares issued and outstanding in the prior year has been restated to 14.1 million and accordingly earning per share is restated. NOTES TO THE FINANCIAL STATEMENTSFOR THE YEAR ENDED 31 DECEMBER, 202124 LOSS PER SHARE (CONTINUED)B) The basic and diluted loss per share is calculated as follows:#REF! #REF!SAR’000Net loss for the year (114,584) (461) Weighted average number of ordinary shares outstanding 14,100 14,100 Basic (loss) per share (SAR) (8.13) (0.03) | 23 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Disclosure of related party transactions [text block] | 21 RELATED PARTY TRANSACTIONS AND BALANCESRelated parties represent major shareholders, directors and key management personnel of the Company, and companies of which they are principal owners and any other entities controlled, jointly controlled or significantly influenced by them. Pricing policies and terms of these transactions are approved by the Company’s management and Board of Directors. The following are the details of the major related party transactions during the period and the related balances: Related parties Nature of transaction Transactions for the year ended Balance receivable / (payable) as at31 December, 31 December, 31 December , 31 December,2021 2020 2021 2020SAR’000 Board of directors Premuim written 145 50 - -Affiliates Premuim written 305 172 1,878 1,881 Claims paid/ paymentreceived - - (187) (811)ACIG Bahrain(Shareholder) Claims paid on behalf ofACIG Bahrain - - 1,985 1,985 Board and audit committee Attendance fees 202 185 - - Remuneration and compensation of BOD Members and Top Executives (Disclose number of top executives)SAR’000 2021 BOD members(Non-Executive Top Executives including the CEO and CFO Salaries and compensation - 5,504Allowances 134 -Annual remuneration 1,035 120End of service indemnities - 410 1,169 6,034SAR’000 2020 BOD members(Non-Executive Top Executives including the CEO and CFO Salaries and compensation - 5,504Allowances 198 -Annual remuneration 1,050 120End of service indemnities - 410 1,248 6,034 | 21 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Disclosure of entity's operating segments [text block] | 20 SEGMENTAL INFORMATION -(CONTINUED)As at December 31, 2020 Medical Motor GeneralAccident Others Total - Insurance Operations Shareholders’Operations Total SAR’000reported FOR THE YEAR ENDED 31 DECEMBER, 2021 20 SEGMENTAL INFORMATION -(CONTINUED) For the year ended 31 December, 2021Total Medical Motor GeneralAccident OthersSAR’000 InsuranceOperations Shareholders’Operations Total OTHER OPERATING (EXPENSES) / INCOME 20 SEGMENTAL INFORMATION - For the year ended 31 December, 2020Total Medical Motor GeneralAccident Others InsuranceOperations Shareholders’Operations Total SAR’000 REVENUES Gross premiums written 126,709 339,228 19,316 29,864 515,117 - 515,117Reinsurance premiums ceded -Local (2,628) - (86) (1,382) (4,096) - (4,096)-Foreign (23,804) - (7,093) (26,140) (57,037) - (57,037) (26,432) - (7,179) (27,522) (61,133) - (61,133)Excess of loss premiums -Local - (1,474) (684) (186) (2,344) - (2,344)-Foreign - (2,212) 309 (277) (2,180) - (2,180) - (3,686) (375) (463) (4,524) - (4,524)Net premiums written 100,277 335,542 11,762 1,879 449,460 - 449,460Changes in unearned premiums, net (6,666) 4,751 (2,264) 140 (4,039) - (4,039)Net premiums earned 93,611 340,293 9,498 2,019 445,421 - 445,421Reinsurance commission income - - 747 3,365 4,112 - 4,112Other underwriting income 2,253 1,816 2,191 - 6,260 - 6,260TOTAL REVENUES 95,864 342,109 12,436 5,384 455,793 - 455,793UNDERWRITING COSTS AND EXPENSES Gross claims paid 123,282 256,486 2,415 659 382,842 - 382,842Reinsurers’ share of claims paid (35,504) (1,630) (613) (376) (38,123) - (38,123)Net claims paid 87,778 254,856 1,802 283 344,719 - 344,719Changes in outstanding claims, net (1,000) (10,856) 1,806 (70) (10,120) - (10,120)Changes in claims incurred but not reported, net 2,872 1,671 796 (6) 5,333 - 5,333Net claims incurred 89,650 245,671 4,404 207 339,932 - 339,932Change in loss adjustment expenses 185 453 126 2 766 - 766Changes in premium deficiency reserve 2,752 4,455 - - 7,207 - 7,207Policy acquisition costs 8,335 20,173 756 1,368 30,632 - 30,632Other underwriting expenses 258 5,475 - - 5,733 - 5,733TOTAL UNDERWRITING COSTS AND EXPENSES 101,180 276,227 5,286 1,577 384,270 - 384,270NET UNDERWRITING INCOME (5,316) 65,882 7,150 3,807 71,523 - 71,523OTHER OPERATING (EXPENSES) / INCOME Release of doubtful debts 4,354 - 4,354General and administrative expenses (73,469) (3,122) (76,591)Commission income on deposits 2,138 510 2,648Investment incomeOther income -12 2,056 2,056- 12TOTAL OTHER OPERATING EXPENSES, NET (66,965) (556) (67,521)Loss for the year 4,002Zakat charge for the year (4,463)Net loss for the year (461)NET INCOME ATTRIBUTED TO THE INSURANCE OPERATIONS (456)NET LOSS ATTRIBUTABLE TO THE SHAREHOLDERS (917) (A SAUDI JOINT STOCK COMPANY) NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER, 202120 SEGMENTAL INFORMATION -(CONTINUED)For the year ended 31 December, 2021Medical Motor Properties and accidentSAR’000Gross premiums writtenIndividual 2,489 374,577 10,074 387,140Micro enterprise 60,300 5,990 1,067 67,357Small 58,004 1,741 4,416 64,161Medium 25,209 789 18,136 44,134Large 13,481 401 15,914 29,796TOTAL GROSS PREMIUMS WRITTEN 159,483 383,498 49,607 592,588For the year ended 31 December, 2020Medical Motor Properties and accidentSAR’000Gross premiums written Individual 6,812 332,415 10,162 349,389Micro enterprise 37,076 4,277 446 41,799Small 50,318 1,369 2,748 54,435Medium 14,291 1,167 6,650 22,108Large 18,212 - 29,174 47,386TOTAL GROSS PREMIUMS WRITTEN 126,709 339,228 49,180 515,117 | 20 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Disclosure of claims/ benefits development table [text block] | 18 CLAIMS DEVELOPMENT TABLEThe following reflects the cumulative incurred claims, including both claims notified and incurred but not reported for each successive accident year at each statement of financial position date, together with the cumulative payments to date. The development of insurance liabilities provides a measure of the Company's ability to estimate the ultimate value of the claimsThe Company aims to maintain adequate reserves in respect of its insurance business in order to protect against adverse future claims experience and developments. The IBNR estimate pertains to claims liability for the periods beginning from year 2015 and earlier onwards whose claim experience has not been fully developed. NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER, 202118 CLAIMS DEVELOPMENT TABLE-(CONTINUED)Claims triangulation analysis is by accident years spanning a number of financial years; Claims development table gross of reinsurance:2021 SAR'000 Accident year or Underwriting year 2015 & Earlier 2016 2017 2018 2019 2020 2021 TOTALAt the end of accident year 608,843 351,010 267,868 331,435 387,920 344,741 446,085 2,737,902One year later 660,630 328,798 266,333 325,348 392,016 333,804 - 2,306,929Two years later 660,291 325,167 264,489 326,328 388,595 - - 1,964,870Three years later 667,977 325,018 265,417 327,777 - - - 1,586,189Four years later 668,800 326,144 265,751 - - - - 1,260,695Five years later 603,691 326,548 - - - - - 930,239Six years later 605,096 - - - - - - 605,096Current estimate of cumulative claims 605,096 326,548 265,751 327,777 388,595 333,804 446,085 2,693,656Cumulative payments to date (602,755) (326,039) (264,346) (324,662) (384,855) (329,819) (355,006) (2,587,482)Liability recognized in statement of financial position 2,341 509 1,405 3,115 3,740 3,985 91,079 106,174Salvage and subrogation (39) 26 15 71 7,686 10,010 - 17,769Premium deficiency reserve - - - - - - 35,727 35,727Outstanding Claims and Reserves 2,236 414 963 1,214 (6,518) (6,222) 42,518 34,605 2020 SAR'000 Accident year or Underwriting year 2014 & Earlier 2015 2016 2017 2018 2019 2020 TOTALAt the end of accident year 321,511 287,332 351,010 267,868 331,435 387,920 344,741 2,291,817One year later 343,396 317,234 328,798 266,333 325,348 392,016 - 1,973,125Two years later 349,209 311,082 325,167 264,489 326,328 - - 1,576,275Three years later 350,195 317,782 325,018 265,417 - - - 1,258,412Four years later 351,991 316,809 326,144 - - - - 994,944Five years later 285,324 318,367 - - - - - 603,691Six years later 285,461 - - - - - - 285,461Current estimate of cumulative claims 285,461 318,367 326,144 265,417 326,328 392,016 344,740 2,258,473Cumulative payments to date (284,044) (316,718) (325,303) (263,353) (321,582) (379,786) (272,952) (2,163,738)Liability recognized in statement of financial 1,417 1,649 841 2,064 4,746 12,230 71,788 94,735Salvage and subrogation 4 9 91 57 90 8,234 8,257 16,742Premium deficiency reserve - - - - - - 9,516 9,516Outstanding Claims and Reserves 1,340 1,591 592 658 1,626 (4,406) 24,693 26,094 | 17 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Disclosure of commitments and contingencies, general [text block] | 14 COMMITMENTS AND CONTINGENCIES The Company’s commitments and contingencies are as follows: 31 December, 31 December, 2021 2020 SAR’000Letters of guarantee | 13 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Disclosure of risk management [abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Disclosure of operational/ process risk [text block] | RISK MANAGEMENT (a) InsuranceThe principal risk the Company faces under insurance contracts is that the actual claims and benefit payments or the timing thereof, differ from expectations. This is influenced by the frequency of claims, severity of claims, actual benefits paid and subsequent development of long–term claims. Therefore, the objective of the Company is to ensure that sufficient reserves are available to cover these liabilities.The Company purchases reinsurance as part of its risks mitigation programme. Reinsurance ceded is placed on both a proportional and non–proportional basis. The majority of proportional reinsurance is quota–share reinsurance which is taken out to reduce the overall exposure of the Company to certain classes of business. Non–proportional reinsurance is primarily excess–of–loss reinsurance designed to mitigate the Company’s net exposure to catastrophe losses. Retention limits for the excess–of–loss reinsurance vary by product line and territory.Amounts recoverable from reinsurers are estimated in a manner consistent with the outstanding claims provision and are in accordance with the reinsurance contracts. Although the Company has reinsurance arrangements, it is not relieved of its direct obligations to its policyholders and thus a credit exposure exists with respect to reinsurance ceded, to the extent that any reinsurer is unable to meet its obligations assumed under such reinsurance arrangements. The Company’s placement of reinsurance is diversified such that it is neither dependent on a single reinsurer nor are the operations of the Company substantially dependent upon any single reinsurance contract. There is no single counterparty exposure that exceeds 36% of total reinsurance assets at the reporting date. NOTES TO THE FINANCIAL STATEMENTSFOR THE YEAR ENDED 31 DECEMBER, 202128 RISK MANAGEMENT-(CONTINUED) Insurance-(Continued)Frequency and severity of claimsThe frequency and severity of claims can be affected by several factors like natural disasters, flood, environmental and economical, atmospheric disturbances, concentration of risks, civil riots etc. The Company manages these risk through the measures described above. The company has limited its risk by imposing maximum claim amounts on certain contracts as well as the use of reinsurance arrangements in order to limit exposure to catastrophic events (e.g., hurricanes, earthquakes and flood damage). The purpose of these underwriting and reinsurance strategies is to limit exposure to catastrophes based on the Company’s risk appetite as decided by management. The overall aim is currently to restrict the impact of a single catastrophic event to approximately 15% of shareholders’ equity on a gross basis and 3% on a net basis. In the event of such a catastrophe, counterparty exposure to a single reinsurer is estimated not to exceed 5% of shareholders’ equity. The Board may decide to increase or decrease the maximum tolerances based on market conditions and other factors.Concentration of insurance riskThe Company monitors concentration of insurance risks primarily by class of business. The major concentration lies in medical segment.The Company also monitors concentration of risk by evaluating multiple risks covered in the same geographical location. For flood or earthquake risk, a complete city is classified as a single location. For fire and property risk a particular building and neighboring buildings, which could be affected by a single claim incident, are considered as a single location. Similarly, for marine risk, multiple risks covered in a single vessel voyage are considered as a single risk while assessing concentration of risk. The Company evaluates the concentration of exposures to individual and cumulative insurance risks and establishes its reinsurance policy to reduce such exposures to levels acceptable to the Company.Since the Company operates majorly in Saudi Arabia, hence, all the insurance risks relate to policies written in Saudi ArabiaSources of uncertainty in estimation of future claim payments The key source of estimation uncertainty at the statement of financial position date relates to valuation of outstanding claims, whether reported or not, and includes expected claims settlement costs. Claims are payable to Policyholders and third parties depending upon the terms of the contract as contained in policy terms and conditions. The principal assumption underlying the liability estimates is that the Company’s future claims development will follow a similar pattern to past claims development experience. This includes assumptions in respect of average claim costs, claim handling costs, claim inflation factors and claim numbers for each accident year. Additional qualitative judgements are used to assess the extent to which past trends may not apply in the future, for example: one–off occurrence; changes in market factors such as public attitude to claiming: economic conditions: as well as internal factors such as portfolio mix, policy conditions and claims handling procedures. Judgement is further used to assess the extent to which external factors such as judicial decisions and government legislation affect the estimates.Considerable judgment by management is required in the estimation of amounts due to policyholders arising from claims made under insurance contracts. Such estimates are necessarily based on assumptions about several factors involving varying and possibly significant degrees of judgment and uncertainty and actual results may differ from management’s estimates resulting in future changes in estimated liabilities. Qualitative judgments are used to assess the extent to which past trends may not apply in the future, for example one-off occurrence, changes in market factors such as public attitude to claiming and economic conditions. Judgment is further used to assess the extent to which external factors such as judicial decisions and government legislation affect the estimates. NOTES TO THE FINANCIAL STATEMENTSFOR THE YEAR ENDED 31 DECEMBER, 202128 RISK MANAGEMENT-(CONTINUED)Insurance-(Continued)Sources of uncertainty in estimation of future claim payments -(Continued)In particular, estimates have to be made both for the expected ultimate cost of claims reported at the statement of financial position date and for the expected ultimate cost of claims incurred but not reported (IBNR) at the statement of financial position date.Process used to decide on assumptionsThe process used to determine the assumptions for calculating the outstanding claim reserve is intended to result in neutral reasonable estimates of the most likely or expected outcome. The nature of the business makes it very difficult to predict with certainty the likely outcome of any particular claim and the ultimate cost of notified claims. Each notified claim is assessed on a separate, case by case basis with due regard to claim circumstances, information available from surveyors and historical evidence of the size of similar claims. Case estimates are reviewed regularly and are updated as and when new information is available.The estimation of IBNR is generally subject to a greater degree of uncertainty than the estimation of the cost of settling claims already notified to the Company, in which case information about the claim event is available. The estimation process takes into account the past claims reporting pattern and details of reinsurance programs.The ultimate cost of outstanding claims is estimated by using a range of standard actuarial claims projection techniques, such as Chain Ladder and Bornheutter-Ferguson methods.The main assumption underlying these techniques is that a Company’s past claims development experience can be used to project future claims development and hence ultimate claims costs. As such, these methods extrapolate the development of paid and incurred losses, average costs per claim and claim numbers based on the observed development of earlier years and expected loss ratios. Historical claims development is mainly analysed by accident years, but can also be further analysed by geographical area, as well as by significant business lines and claim types. Large claims are usually separately addressed, either by being reserved at the face value of loss adjuster estimates or separately projected in order to reflect their future development. In most cases, no explicit assumptions are made regarding future rates of claims inflation or loss ratios. Instead, the assumptions used are those implicit in the historical claims development data on which the projections are based. Additional qualitative judgement is used to assess the extent to which past trends may not apply in future, (e.g., to reflect one-off occurrences, changes in external or market factors such as public attitudes to claiming, economic conditions, levels of claims inflation, judicial decisions and legislation, as well as internal factors such as portfolio mix, policy features and claims handling procedures) in order to arrive at the estimated ultimate cost of claims that present the likely outcomefrom the range of possible outcomes, taking account of all the uncertainties involved.The premium liabilities have been determined such that the total premium liability provisions (unearned premium reserve and premium deficiency reserve in result of liability adequacy test) would be sufficient to service the future expected claims and expenses likely to occur on the unexpired policies as at the statement of financial position date. The expected future liability is determined using estimates and assumptions based on the experience during the expired period of the contracts and expectations of future events that are believed to be reasonable. NOTES TO THE FINANCIAL STATEMENTSFOR THE YEAR ENDED 31 DECEMBER, 202128 RISK MANAGEMENT-(CONTINUED)Insurance-(Continued)Sensitivity analysisThe Company believes that the estimated claim liabilities under insurance contracts disclosed in the financial statements outstanding at the year-end are considered to be adequate. However, these amounts are not certain and actual payments may differ from the claims liabilities provided in the financial statements. The insurance claim liabilities are sensitive to the various assumptions. It has not been possible to quantify the sensitivity of specific variable such as legislative changes or uncertainty in the estimation process.A hypothetical 2% change in the claim ratio, net of reinsurance, would impact net underwriting income/ (loss) as follows;SAR’000 31 December, 31 December, 2021 2020 Income from insurance operationsImpact of change in claim ratio by - 2% Medical 31,582 (3,444)Motor (67,594) 72,688General Accident 7,598 7,340Others 26,932 3,846 (1,482) 80,430SAR’000 31 December, 31 December, 2021 2020 Income from insurance operationsImpact of change in claim ratio by + 2% Medical 26,820 (14,677)Motor (81,650) 31,852General Accident 7,114 6,200Others 26,860 3,604 (20,856) 26,979(b) Reinsurance riskIn order to limit the financial exposure arising from large claims, the Company, in the normal course of business, enters into agreements with other parties for reinsuring its exposures.To minimize its exposure to significant losses from reinsurer insolvencies, the Company evaluates the financial condition of its reinsurers and monitors concentrations of credit risk arising from similar geographic regions, activities or economic characteristics of the reinsurers. NOTES TO THE FINANCIAL STATEMENTSFOR THE YEAR ENDED 31 DECEMBER, 2021 28(b) RISK MANAGEMENT-(CONTINUED)Reinsurance risk-(Continued) Reinsurers are selected using the following parameters and guidelines set by the Company’s Board of Directors. The criteria may be summarized as follows: - Minimum acceptable credit rating by recognized rating agencies (e.g. S&P) that is not lower than BBB or equivalent- Reputation of particular reinsurance companies- Existing or past business relationship with the reinsurer.Furthermore, the financial strength and managerial and technical expertise as well as historical performance of the reinsurers, wherever applicable, are thoroughly reviewed by the Company and agreed to pre-set requirements of the Company’s Board of Directors before approving them for exchange of reinsurance business. As at 31 December 2019 and2018, there is no significant concentration of reinsurance balances.Reinsurance ceded contracts do not relieve the Company from its obligations to policyholders and as a result the Company remains liable for the portion of outstanding claims reinsured to the extent that the reinsurer fails to meet the obligations under the reinsurance agreements.(c) Market RiskMarket risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in market prices. Market risk comprises three types of risk: foreign exchange rates (currency risk), market interest rates (interest rate risk) and market prices (price risk). The Company’s market risk policy sets out the assessment and determination of what constitutes market risk for the Company. Compliance with the policy is monitored and exposures and breaches are reported to the Company’s Board Investment Committee and Risk committee. The policy is reviewed regularly for pertinence and for changes in the risk environment. Guidelines are set for asset allocation and portfolio limit structure, to ensure that assets back specific policyholders’ liabilities and that assets are held to deliver income and gains for policyholders and shareholders which are in line with their expectations. The Company stipulates diversification benchmarks by type of instrument and geographical area, as the Company is exposed to guaranteed bonuses, cash and annuity options when interest rates fall. There is strict control over hedging activities (e.g., equity derivatives are only permitted to be held to facilitate portfolio management or to reduce investment risk).The Board of Directors of the Company ensure that the overall market risk exposure is maintained at prudent levels and is consistent with the available capital. While the Board gives a strategic direction and goals, risk management function related to market risk is mainly the responsibility of Investment Committee team. The team prepares forecasts showing the effects of various possible changes in market conditions related to risk exposures. This risk is being mitigated through the proper selection of securities. Company maintains diversified portfolio and performs regular monitoring of developments in related markets. In addition, the key factors that affect stock and sukuk market movements are monitored, including analysis of the operational and financial performance of investees.Market risk comprises of three types of risk: currency risk, commission rate risk and other price riskCurrency RiskCurrency risk is the risk that the value of a financial instrument will fluctuate due to changes in foreign exchange rates. TheCompany’s transactions are principally in Saudi Arabian Riyals. So that the foreign currency risk is not significant. Commission Rate RiskThe Company invests in securities and has deposits that are subject to commission rate risk. Commission rate risk to the Company is the risk of changes in commission rates reducing the overall return on its fixed commission rate bearing securities. The Commission rate risk is limited by monitoring changes in commission rates and by investing in floating rate instruments.An increase or decrease of 50 basis points in interest yields would result in a change in the income for the year of SAR0.91 million (2020: SAR 1.1 million).The commission bearing investments of the Company and their maturities as at December 31, 2021 and 2020 are as follows:Less than 1 Year More than 1 Year TotalInsurance Operations 20212020Shareholders Operations20212020 182,367119,331-61,050 - 182,367- 119,331- -25,000 86,050 Other Price RiskOther price risk is the risk that the fair value or future cash flows of financial instruments will fluctuate because of changes in market prices (other than those arising from commission rate risk or currency risk), whether those changes are caused by factors specific to the individual financial instrument or its issuer, or factors affecting all similar financial instruments traded in the market.The Company's investments amounting to SAR 28.7 million (2020: SAR 27.3 million) are susceptible to market price risk arising from uncertainty about the future value of invested securities. The Company limits this nature of market risk by diversifying its invested portfolio and by actively monitoring the developments in markets.The impact of hypothetical change of a 10% increase and 10% decrease in the market prices of investments onCompany's profit would be as follows: Fair value change E f f ect o n Co mpa ny ’s pro f it SR'000 SR'000 31 December 202131 December 2020 + / - 10%+ / - 10% +-2880+-2734 The sensitivity analysis presented is based upon the portfolio position as at 31 December 2021 and 2020. Accordingly, the sensitivity analysis prepared is not necessarily indicative of the effect on the Company's assets of future movements in the value of investments held by the Company. NOTES TO THE FINANCIAL STATEMENTSFOR THE YEAR ENDED 31 DECEMBER, 2021 28(d) RISK MANAGEMENT-(CONTINUED)Credit Risk Credit risk is the risk that one party to a financial instrument will fail to discharge an obligation and cause the other party to incur a financial loss. For all classes of financial instruments held by the Company, the maximum credit risk exposure to the Company is the carrying value as disclosed in the statement of financial position.The table below shows the maximum exposure to credit risk for the relevant components of the statement of financial positionSAR’0002021 2020ASSETS - INSURANCE OPERATIONSCash and cash equivalents 52,973 69,686Premiums and reinsurers’ receivable – net 98,415 98,638Reinsurers’ share of outstanding claims 12,955 11,908 Reinsurers’ share of claims incurred but not reported 8,498 8,020 Prepayments and other receivables 57,950 60,076230,791 248,328SAR’0002021 2020Income from insurance operations Cash and cash equivalents - 75,251Available-for-sale investments 50,721 49,259 50,721 124,510Concentration of credit riskConcentration of credit risk exists when changes in economic or industry factors similarly affect groups of counterparties whose aggregate credit exposure is significant in relation to the Company’s total credit exposure. Approximately 100% (2020: approximately 100%) of the Company’s underwriting activities are carried out in Saudi Arabia. The Company’s portfolio of financial instruments is broadly diversified and transactions are entered into with diverse credit-worthy counterparties thereby mitigating any significant concentrations of credit risk. 28 RISK MANAGEMENT-(CONTINUED) Credit Risk-(Continued) Credit risk exposureInvestments: SAR’0002021 2020 2021 2020 2021 2020Investment grade Non-investment grade Unrated -Available for sale - - - - - -Debt instruments - - 20,000 20,000 - -Equities 11,508 11,177 - - - -Other 17,209 16,159 - - 1,923 1,923 Premium and reinsurancebalances receivable: - - - - - - Policyholders’ - - - - 99,468 93,309Due from a related party - - - - 6,447 1,985Reinsurance receivables - - - - 1,985 5,329Total 28,717 27,336 20,000 20,000 109,823 102,546 To manage the liquidity risk arising from financial liabilities mentioned above, the Company holds liquid assets comprising cash and cash equivalents and investment securities. These assets can be readily sold to meet liquidity requirements.The assets with maturity less than one year are expected to realize as follows: Deposits are expected to be matured within 6 months from the date of placement. Cash and bank balances are available on demand. Reinsurers share of outstanding claims majorly pertain to property and casualty segment and are generally realized within 6 to 12 months based on settlement of balances with reinsurers.The liabilities with maturity less than one year are expected to settle as follows: Reinsurers’ balances payable are settled on a quarterly basis as per terms of reinsurance agreements. As per the Regulation, all insurance claims need to be settled within the time limits specified in this regard. Majority of gross outstanding claims are expected to be settled within the time limits set in this regard subject to meeting all the documentation requirements. Property and casualty policies due to the inherent nature are generally settled within 45 days from the date of receipt of loss adjustor report The claims payable, accrued expenses and other liabilities are expected to settle within a period of 1-3 months from the period end date. Surplus distribution payable is to be settled within 6 months of annual general meeting in which financial statements are approved(e) Operational RiskOperational risk is the risk of direct or indirect loss arising from a wide variety of causes associated with the processes, technology and infrastructure supporting the Company’s operations either internally within the Company or externally at the Company’s service providers, and from external factors other than credit, market and liquidity risks such as those arising from legal and regulatory requirements and generally accepted standards of investment management behavior. Operational risks arise from all of the Company’s activitiesThe Company’s objective is to manage operational risk so as to balance limiting of financial losses and damage to its reputation with achieving its investment objective of generating returns for investors. The primary responsibility for the development and implementation of controls over operational risk rests with the Board of Directors. This responsibility encompasses the controls in the following areas:- Requirements for appropriate segregation of duties between various functions, roles and responsibilities;- Requirements for the reconciliation and monitoring of transactions;- Compliance with regulatory and other legal requirements;- Documentation of controls and procedures;- Requirements for the periodic assessment of operational risks faced, and the adequacy of controls and procedures to address the risks identified;- Ethical and business standards; and- Risk mitigation policies and procedures.Senior Management ensures that the Company's staff has adequate training and experience and fosters effective communication related to operational risk management. NOTES TO THE FINANCIAL STATEMENTS | 28 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Disclosure of comparative figures [text block] | SUBSEQUENT EVENTSSubsequent to the year end, the company initiated and completed the process of issuance of right shares. The details are given in Note 23. | 31 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Disclosure of board of director's approval of the financial statements [text block] | APPROVAL OF THE FINANCIAL STATEMENTSThese financial statements have been approved by the Board of Directors on 29 March 2022 (corresponding to Shaʻban 26, 1443 AH) | 32 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Disclosure of other notes relevant to understanding of financial statements [text block] | FAIR VALUES OF FINANCIAL INSTRUMENTSFair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The fair value measurement is based on the presumption that the transaction takes place either: in the accessible principal market for the asset or liability, or in the absence of a principal market, in the most advantages accessible market for the asset or liability.The fair values of on-balance sheet financial instruments are not significantly different from their carrying amounts included in the financial statement.Determination of fair value and fair value hierarchyThe Company uses the following hierarchy for determining and disclosing the fair value of financial instruments:Level 1: quoted prices in active markets for the same or identical instrument that an entity can access at the measurement date;Level 2: quoted prices in active markets for similar assets and liabilities or other valuation techniques for which all significant inputs are based on observable market data; andLevel 3: valuation techniques for which any significant input is not based on observable market data.a) Carrying amount and fair valueThe following table shows the carrying amount and fair values of financial assets and financial liabilities, including their levels in the fair value hierarchy for financial instruments measured at fair value. It does not include fair value information for financial assets and financial liabilities not measured at fair value if the carrying amount is not considered to reasonably approximate fair value. Shareholders' operationsSAR’000s31 December, 2021Financial assets measured at fair valueAvailable-for-sales investments CarryingValue Level 1 Level 2 Level 3 Total Investment in Sukuk 20,000 - - 20,000 20,000Quoted securities 11,508 11,508 - - 11,508Quoted local real estate fund 17,290 17,290 - - 17,29048,798 28,798 - 20,000 48,798The fair value of unquoted securities at level 3 is not materially different than its cost price.Investment in Najm amounting to SR 1,923,000 is excluded from above table because it is carried at cost and its fair value was not determined.Shareholders' operationsSAR’000s Value Level 1 Level 2 Level 3 Total31 December, 2020 Financial assets measured at fair value Available-for-sales investments Investment in Sukuk 20,000 - - 20,000 20,000Quoted securities 11,177 11,177 - - 11,177Quoted local real estate fund 16,159 16,159 - 16,159 47,336 27,336 - 20,000 47,336During the year ended 31 December 2021, there were no movements between the levels. 19 FAIR VALUES OF FINANCIAL INSTRUMENTS0- (CONTINUED)The following table shows the valuation techniques used in measuring Level 2 and Level 3 fair values at 31 December 2021 and 31 December 2020, as well as the significant unobservable inputs used. Type Valuation technique Significant unobservable inputs Inter-relationship between significant unobservable inputs and fair value measurement. Available for sale equity securities(unquoted)/ Investments held asFVSI (unquoted) Market comparison technique:The valuation model is based on market multiples derived from quoted prices of companies comparable to investee and the expected EBITDA of the investee. This estimate is adjusted for the effect of non- marketability of the equity securities. Forecast annual revenuegrowth rate Forecast EBITDA marginAdjusted market multiple. The estimated fair value would increase(decrease) if: The annual revenue growth rate were higher (lower); The EBITDA margin were higher(lower); or The adjusted market multiple were lower(higher).Generally, a change in the annual revenue growth is accompanied by a directionally similar change in EBITDA margin.Corporate debt securities / Held tomaturity investments Market comparison technique:The fair values are based on broker quotes. Similar contracts are traded in an active market and the quotes reflect the actual transactions in similar instruments. Not applicable. Not applicable. | 18 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Disclosure of derivatives and hedges[text block] |
Insurance 31 December, 2021 Shareholders’
Insurance 31 December, 2020 Shareholders’ operations
FOR THE YEAR ENDED 31 DECEMBER, 2021 29 SUPPLEMANTARY INFORMATION (CONTINUED) STATEMENT OF INCOME SAR ’0 0 0 For the year ended 31 December 2021 31 December, 2021 31 December, 2020 REVENUES
operations Total
operations Total Gross written Premuim 592,588 - 592,588 515,117 - 515,117 Reinsurance premiums ceded -Local (1,728) - (1,728) (4,096) - (4,096) -Foreign (72,464) - (72,464) (57,037) - (57,037) (74,192) - (74,192) (61,133) - (61,133) Excess of loss expenses
29 SUPPLEMANTARY INFORMATION (CONTINUED) STATEMENT OF INCOME SAR ’0 0 0 For the year ended 31 December 2021 31 December, 2021 31 December, 2020 Insurance operations
operations Total
operations Total
Net result after transfer of surplus to shareholders
OTHER COMPREHENSIVE INCOME / (LOSS) ITEMS THAT WILL NOT BE RECLASSIFIED TO STATEMENT OF INCOME IN SUBSEQUENT PERIODS - Actuarial gains / (losses) on employees’ terminal benefits
ITEMS THAT ARE OR MAY BE RECLASSIFIED TO STATEMENTS OF INCOME IN SUBSEQUENT PERIOD Available-for-sale investments: -Net change in fair value 1,462 1,462 - 3,153 3,153 TOTAL COMPREHENSIVE (LOSS) / INCOME FOR THE YEAR (473) (113,122) (113,595) 223 2,236 2,459 NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER, 2021 29SUPPLEMANTARY INFORMATION (CONTINUED) STATEMENT OF CASH FLOWS Insurance operations Shareholders’ operations Total SAR ’000 Insurance operations Shareholders’ operations Total For the year ended 31 December, 2021 For the year ended 31 December, 2020
Cash and cash equivalents, end of the period 52,973 - 52,973 69,686 75,251 144,937 30 COMPARATIVE FIGURES Certain prior period figures have been reclassified to conform to current period presentation (if applicable). 31 IMPACT OF COVID-19 On 11 March 2020, the World Health Organisation (“WHO”) declared the Coronavirus (“COVID-19”) outbreak as a pandemic in recognition of its rapid spread across the globe. This outbreak has also affected the GCC region including the Kingdom of Saudi Arabia. Governments all over the world took steps to contain the spread of the virus. Saudi Arabia in particular has implemented closure of borders, released social distancing guidelines and enforced country wide lockdowns and curfews. In response to the spread of the Covid-19 virus in the GCC and other territories (to be tailored based on company’s operations) where the Company operates and its consequential disruption to the social and economic activities in those markets, the Company’s management has proactively assessed its impacts on its operations and has taken a series of proactive and preventative measures and processes to ensure: the health and safety of its employees and the wider community where it is operating the continuity of its business throughout the Kingdom is protected and kept intact. The major impact of Covid-19 pandemic was seen in medical and motor line of business. As with any estimate, the projections and likelihoods of occurrence are underpinned by significant judgment and rapidly evolving situation and uncertainties surrounding the duration and severity of the pandemic, and therefore, the actual outcomes may be different to those projected. The management of the Company believes that any potential lockdown measures being reintroduced will not materially affect the underlying demand for the Company’s insurance products and forecast. Further, the Company continues to monitor the surge of the new variant closely although at this time management is not aware of any factors that are expected to change the impact of the pandemic on the Company’s operations during 2022 or beyond. However, the Company’s management believes that the Covid-19 pandemic has had no material effects on Company’s reported results for the year ended 31 December 2021. | 29 |